Section 11

EurekaMag PDF full texts Chapter 10,120


Nakagawa, M.; Miyamoto, T.; Ohkuma, M.; Tsuda, M. 1999: Action spectrum for the photophobic response of Ciona intestinalis (Ascidieacea, Urochordata) larvae implicates retinal protein. Photochemistry and Photobiology 70(3): 359-362
Tyystjärvi, T.; Tuominen, I.; Herranen, M.; Aro, E-Mari.; Tyystjärvi, E. 2002: Action spectrum of psbA gene transcription is similar to that of photoinhibition in Synechocystis sp. PCC 6803. FEBS Letters 516(1-3): 167-171
Magen, H.; Cohen, A. 2002: Action-based and vision-based selection of input: two sources of control. Psychological Research 66(4): 247-259
Little, T.D.; Stetsenko, A.; Maier, H. 1999: Action-control beliefs and school performance: A longitudinal study of Moscow children and adolescents. International Journal of Behavioral Development 23(3): 799-823
Russell, J.; Hill, E.L. 2001: Action-monitoring and intention reporting in children with autism. Journal of Child Psychology and Psychiatry and Allied Disciplines 42(3): 317-328
Dubrowski, A.; Carnahan, H. 2002: Action-perception dissociation in response to target acceleration. Vision Research 42(11): 1465-1473
Schoner, G.; Dijkstra, T.M.H.; Jeka, J.J. 1998: Action-perception patterns emerge from coupling and adaptation. Ecological Psychology 10(3-4): 323-346
Tosetti, P.; Taglietti, V.; Toselli, M. 1999: Action-potential-like depolarizations relieve opioid inhibition of N-type Ca2+ channels in NG108-15 cells. Pflugers Archiv: European Journal of Physiology 437(3): 441-448
Albini, G.; Falque, M.; Joets, J. 2003: ActionMap: A web-based software that automates loci assignments to framework maps. Nucleic Acids Research 31(13): 3815-3818
Engblom, A.C.; Johansen, F.F.; Kristiansen, U. 2003: Actions and interactions of extracellular potassium and kainate on expression of 13 gamma-aminobutyric acid type a receptor subunits in cultured mouse cerebellar granule neurons. Journal of Biological Chemistry 278(19): 16543-16550
Lackey, B.R.; Gray, S.L.; Henricks, D.M. 2000: Actions and interactions of the IGF system in Alzheimer's disease: review and hypotheses. Growth Hormone and Igf Research: Official Journal of the Growth Hormone Research Society and the International Igf Research Society 10(1): 1-13
Kulesza, V. 2001: Actions menees par l'ONF dans les Alpes-Maritimes pour connaitre et proteger la flore. Revue Forestiere Francaise Numero Special (Nancy) (2001): 296-299
Newberry, N.R.; Footitt, D.R.; Papanastassiou, V.; Reynolds, D.J. 1999: Actions of 5-HT on human neocortical neurones in vitro. Brain Research 833(1): 93-100
Shaw, P.J.; Charles, S.L.; Salt, T.E. 1999: Actions of 8-Bromo-cyclic-GMP on neurones in the rat thalamus in vivo and in vitro. Brain Research 833(2): 272-277
Bi, S.; Moran, T.H. 2002: Actions of CCK in the controls of food intake and body weight: lessons from the CCK-A receptor deficient OLETF rat. Neuropeptides 36(2-3): 171-181
Monteiro, H.S.; da Silva, I.M.; Martins, A.M.; Fonteles, M.C. 2001: Actions of Crotalus durissus terrificus venom and crotoxin on the isolated rat kidney. Brazilian Journal of Medical and Biological Research 34(10): 1347-1352
Weiss, J.M.; Krautmacher, B.; Polack, S.; Diedrich, K.; Ortmann, O. 2003: Actions of GnRH antagonists on IGF-II, IGF-binding protein-2 and pregnancy-associated plasma protein-A in human granulosa-lutein cells. European Journal of Endocrinology 149(1): 31-37
Soares de Moura, R.S.; Leão, M.C.; Castro Resende, A.C.; Moreira, C.F.; Sena, K.M.; Silveira, S.S.; Lima, A.F.; Nunes, F.R.; Mesquita Ferreira, A.G. 2000: Actions of L-NAME and methylene blue on the hypotensive effects of clonidine and rilmenidine in the anesthetized rat. Journal of Cardiovascular Pharmacology 35(5): 791-795
Nasu, T.; Magami, G. 2000: Actions of Mn(2+) in the presence of ionophore A23187 in taenia coli of guinea-pig. Pharmacological Research 41(4): 397-403
Spinella, M.; Znamensky, V.; Moroz, M.; Ragnauth, A.; Bodnar, R.J. 1999: Actions of NMDA and cholinergic receptor antagonists in the rostral ventromedial medulla upon beta-endorphin analgesia elicited from the ventrolateral periaqueductal gray. Brain Research 829(1-2): 151-159
Li, C.; Gui, P.; He, X. 1999: Actions of NO and iNOS on endotoxin induced rat acute lung injury and affection of Rhubarb on them. Chinese Medical Journal (English Edition) 112(11): 977
Tanović, A.; Jiménez, M.; Fernández, E. 2001: Actions of NO donors and endogenous nitrergic transmitter on the longitudinal muscle of rat ileum in vitro: Mechanisms involved. Life Sciences 69(10): 1143-1154
Porcello, D.M.; Smith, S.D.; Huguenard, J.R. 2003: Actions of U-92032, a T-type Ca2+ channel antagonist, support a functional linkage between I(T) and slow intrathalamic rhythms. Journal of Neurophysiology 89(1): 177-185
Xin, Y.; Hurwitz, I.; Perrins, R.; Evans, C.G.; Alexeeva, V.; Weiss, K.R.; Kupfermann, I. 1999: Actions of a pair of identified cerebral-buccal interneurons (CBI-8/9) in Aplysia that contain the peptide myomodulin. Journal of Neurophysiology 81(2): 507-520
Bilezikjian, L.M.; Blount, A.L.; Corrigan, A.Z.; Leal, A.; Chen, Y.; Vale, W.W. 2001: Actions of activins, inhibins and follistatins: Implications in anterior pituitary function. Clinical and Experimental Pharmacology and Physiology 28(3): 244-248
Shiozaki, S.; Ichikawa, S.; Nakamura, J.; Kitamura, S.; Yamada, K.; Kuwana, Y. 1999: Actions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP. Psychopharmacology 147(1): 90-95
Franowicz, J.S.; Arnsten, A.F.T. 2002: Actions of alpha-2 noradrenergic agonists on spatial working memory and blood pressure in rhesus monkeys appear to be mediated by the same receptor subtype. Psychopharmacology 162(3): 304-312
Cleary, L.; Docherty, J.R. 2003: Actions of amphetamine derivatives and cathinone at the noradrenaline transporter. European Journal of Pharmacology 476(1-2): 31-34
Arendshorst, W.J.; Brännström, K.; Ruan, X. 1999: Actions of angiotensin II on the renal microvasculature. Journal of the American Society of Nephrology: Jasn 10(Suppl): S149-S161
Tan, L.M.; Sim, M.K. 2000: Actions of angiotensin peptides on the rabbit pulmonary artery. Life Sciences 66(19): 1839-1847
Mamas, M.A.; Terrar, D.A. 2001: Actions of arachidonic acid on contractions and associated electrical activity in guinea-pig isolated ventricular myocytes. Experimental Physiology 86(4): 437-449
Tanaka, H.; Ogasa, H.; Barnes, J.; Liang, C.T. 1999: Actions of bFGF on mitogenic activity and lineage expression in rat osteoprogenitor cells: Effect of age. Molecular and Cellular Endocrinology 150(1-2): 1-10
Scharfman, H.E.; Goodman, J.H.; Sollas, A.L. 1999: Actions of brain-derived neurotrophic factor in slices from rats with spontaneous seizures and mossy fiber sprouting in the dentate gyrus. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 19(13): 5619-5631
Taniguchi, N.; Takada, N.; Kimura, F.; Tsumoto, T. 2000: Actions of brain-derived neurotrophic factor on evoked and spontaneous EPSCs dissociate with maturation of neurones cultured from rat visual cortex. Journal of Physiology 527 Pt 3: 579-592
Shim, S.S.; Grant, E.R.; Singh, S.; Gallagher, M.J.; Lynch, D.R. 1999: Actions of butyrophenones and other antipsychotic agents at NMDA receptors: Relationship with clinical effects and structural considerations. Neurochemistry International 34(2): 167-175
Ross, R.A.; Coutts, A.A.; Mcfarlane, S.M.; Anavi Goffer, S.; Irving, A.J.; Pertwee, R.G.; Macewan, D.J.; Scott, R.H. 2001: Actions of cannabinoid receptor ligands on rat cultured sensory neurones: Implications for antinociception. Neuropharmacology 40(2): 221-232, 4 January
Cheung, S.; Kwan, T.K.; Huang, S.J.; Kwan, C.Y. 2000: Actions of cardiotoxin on cytosolic free Ca2+ in the presence of a calcium-free environment, calcium channel blockers and the polyamine spermine in vascular smooth muscle and endothelial cells. Biomedical Research 11(2): 131-136
Stanley, S.A.; Small, C.J.; Murphy, K.G.; Rayes, E.; Abbott, C.R.; Seal, L.J.; Morgan, D.G.; Sunter, D.; Dakin, C.L.; Kim, M.S.; Hunter, R.; Kuhar, M.; Ghatei, M.A.; Bloom, S.R. 2001: Actions of cocaine- and amphetamine-regulated transcript (CART) peptide on regulation of appetite and hypothalamo-pituitary axes in vitro and in vivo in male rats. Brain Research 893(1-2): 186-194
Liu, S.; Hu, H.Z.; Gao, C.; Gao, N.; Wang, G.; Wang, X.; Gao, X.; Xia, Y.; Wood, J.D. 2003: Actions of cysteinyl leukotrienes in the enteric nervous system of guinea-pig stomach and small intestine. European Journal of Pharmacology 459(1): 27-39, 10 January
Kamisuki, S.; Murakami, C.; Ohta, K.; Yoshida, H.; Sugawara, F.; Sakaguchi, K.; Mizushina, Y. 2002: Actions of derivatives of dehydroaltenusin, a new mammalian DNA polymerase alpha-specific inhibitor. Biochemical Pharmacology 63(3): 421-427
Ozaki, M.; Masuda, Y.; Kishioka, S.; Yamamoto, H. 2003: Actions of domperidone on the opioid system in isolated guinea-pig ileum: Differences between dopamine antagonists on opioid system. Autonomic and Autacoid Pharmacology 23(1): 57-62
Yajiri, Y.; Huang, L.Y. 2000: Actions of endomorphins on synaptic transmission of Adelta-fibers in spinal cord dorsal horn neurons. Journal of Biomedical Science 7(3): 226-231
Lázár, Z.; Benkó, R.; Bölcskei, K.; Rumbus, Z.; Wolf, M.; Holzer, P.; Maggi, C.A.; Barthó, L. 2003: Actions of endothelin and corticotropin releasing factor in the guinea-pig ileum: No evidence for an interaction with capsaicin-sensitive neurons. Neuropeptides 37(4): 220-232
Maric, C.; Aldred, G.P.; Antoine, A.M.; Eitle, E.; Dean, R.G.; Williams, D.A.; Harris, P.J.; Alcorn, D. 1999: Actions of endothelin-1 on cultured rat renomedullary interstitial cells are modulated by nitric oxide. Clinical and Experimental Pharmacology and Physiology 26(5-6): 392-398
Wu, S.N.; Li, H.F.; Chiang, H.T. 2000: Actions of epoxyeicosatrienoic acid on large-conductance Ca(2+)-activated K(+) channels in pituitary GH(3) cells. Biochemical Pharmacology 60(2): 251-262
Akiyama, H.; Oono, T.; Huh, W-K.; Yamasaki, O.; Ogawa, S.; Katsuyama, M.; Ichikawa, H.; Iwatsuki, K. 2002: Actions of farnesol and xylitol against Staphylococcus aureus. Chemotherapy 48(3): 122-128
Ueno, S.; Trudell, J.R.; Eger, E.I.; Harris, R.A. 1999: Actions of fluorinated alkanols on GABA(A) receptors: relevance to theories of narcosis. Anesthesia and Analgesia 88(4): 877-883
Liu, S.; Hu, H-Zhen.; Gao, C.; Gao, N.; Xia, Y.; Wood, J.D. 2003: Actions of galanin on neurotransmission in the submucous plexus of guinea pig small intestine. European Journal of Pharmacology 471(1): 49-58
Weiss, J.M.; Oltmanns, K.; Gürke, E.M.; Polack, S.; Eick, F.; Felberbaum, R.; Diedrich, K.; Ortmann, O. 2001: Actions of gonadotropin-releasing hormone antagonists on steroidogenesis in human granulosa lutein cells. European Journal of Endocrinology 144(6): 677-685
Lee, J.J.; Croucher, M.J. 2003: Actions of group I and group II metabotropic glutamate receptor ligands on 5-hydroxytryptamine release in the rat cerebral cortex in vivo: Differential roles in the regulation of central serotonergic neurotransmission. Neuroscience 117(3): 671-679
Engelberg, H. 1999: Actions of heparin that may affect the malignant process. Cancer 85(2): 257-272
Hemming, J.M.; Guarraci, F.A.; Firth, T.A.; Jennings, L.J.; Nelson, M.T.; Mawe, G.M. 2000: Actions of histamine on muscle and ganglia of the guinea pig gallbladder. American Journal of Physiology. Gastrointestinal and Liver Physiology 279(3): G622-G630
Adams, M.B.; Mcmillen, I.C. 2000: Actions of hypoxia on catecholamine synthetic enzyme mRNA expression before and after development of adrenal innervation in the sheep fetus. Journal of Physiology 529 Pt 3: 519-531
Sorianello, E.; Schillaci, R.; Chamson-Reig, A.; Lux-Lantos, V.; Libertun, C. 2002: Actions of immunosuppressor drugs on the development of an experimental ovarian tumor. Experimental Biology and Medicine 227(8): 658-664
Watson, G.B. 2001: Actions of insecticidal spinosyns on gamma-aminobutyric acid responses from small-diameter cockroach neurons. Pesticide biochemistry and physiology 71(1): 20-28
Iwadate, H.; Sugisaki, T.; Kudo, M.; Kizuki, K. 2003: Actions of insulin-like growth factor binding protein-5 (IGFBP-5) are potentially regulated by tissue kallikrein in rat brains. Life Sciences 73(24): 3149-3158
Benoliel, R.; Eliav, E.; Mannes, A.J.; Caudle, R.M.; Leeman, S.; Iadarola, M.J. 1999: Actions of intrathecal diphtheria toxin-substance P fusion protein on models of persistent pain. Pain 79(2-3): 243-253
Scott, D.A.; Wright, C.E.; Angus, J.A. 2002: Actions of intrathecal omega-conotoxins CVID, GVIA, MVIIA, and morphine in acute and neuropathic pain in the rat. European Journal of Pharmacology 451(3): 279-286
Abramov, A.Y.; Duchen, M.R. 2003: Actions of ionomycin, 4-BrA23187 and a novel electrogenic Ca2+ ionophore on mitochondria in intact cells. Cell Calcium 33(2): 101-112
Procter, M.J.; Houghton, A.K.; Faber, E.S.; Chizh, B.A.; Ornstein, P.L.; Lodge, D.; Headley, P.M. 1998: Actions of kainate and AMPA selective glutamate receptor ligands on nociceptive processing in the spinal cord. Neuropharmacology 37(10-11): 1287-1297
Kunst, G.; Martin, E.; Graf, B.M.; Hagl, S.; Vahl, C.F. 1999: Actions of ketamine and its isomers on contractility and calcium transients in human myocardium. Anesthesiology 90(5): 1363-1371
Tung, Y.C.; Hewson, A.K.; Dickson, S.L. 2001: Actions of leptin on growth hormone secretagogue-responsive neurones in the rat hypothalamic arcuate nucleus recorded in vitro. Journal of Neuroendocrinology 13(2): 209-215
Wondmikun, Y.; Soukup, T.; Asmussen, G. 2003: Actions of lyotropic anions on the mechanical properties of fast and slow twitch rat muscles at different temperatures. Physiological Research 52(1): 123-129
Reiter, R.J.; Tan, D.X.; Osuna, C.; Gitto, E. 2000: Actions of melatonin in the reduction of oxidative stress. A review. Journal of Biomedical Science 7(6): 444-458
Kohno, T.; Kumamoto, E.; Baba, H.; Ataka, T.; Okamoto, M.; Shimoji, K.; Yoshimura, M. 2000: Actions of midazolam on GABAergic transmission in substantia gelatinosa neurons of adult rat spinal cord slices. Anesthesiology 92(2): 507-515
Burbridge, D.; Wallis, M. 2001: Actions of monoclonal antibodies on the activity of human growth hormone (GH) in an in vitro bioassay. Molecular and Cellular Endocrinology 174(1-2): 11-19
Kumarnsit, E.; Johnstone, L.E.; Leng, G. 2003: Actions of neuropeptide Y and growth hormone secretagogues in the arcuate nucleus and ventromedial hypothalamic nucleus. European Journal of Neuroscience 17(5): 937-944
Vaughan, C.W.; Connor, M.; Jennings, E.A.; Marinelli, S.; Allen, R.G.; Christie, M.J. 2001: Actions of nociceptin/orphanin FQ and other prepronociceptin products on rat rostral ventromedial medulla neurons in vitro. Journal of Physiology 534(Pt 3): 849-859
Kohno, T.; Kumamoto, E.; Higashi, H.; Shimoji, K.; Yoshimura, M. 1999: Actions of opioids on excitatory and inhibitory transmission in substantia gelatinosa of adult rat spinal cord. Journal of Physiology 518: 803-813
Katayama, Y.; Homma, T.; Honda, K.; Hirai, K. 2003: Actions of orexin-A in the myenteric plexus of the guinea-pig small intestine. Neuroreport 14(11): 1515-1518
Condés-Lara, M.; González, N.Marina.; Martínez-Lorenzana, G.; Delgado, O.Luis.; Freund-Mercier, M.José. 2003: Actions of oxytocin and interactions with glutamate on spontaneous and evoked dorsal spinal cord neuronal activities. Brain Research 976(1): 75-81
Sutarmo Setiadji, V.; Shibuya, I.; Kabashima, N.; Ibrahim, N.; Harayama, N.; Ueta, Y.; Yamashita, H. 1998: Actions of prostaglandin E2 on rat supraoptic neurones. Journal of Neuroendocrinology 10(12): 927-936
Olson, K.K.; Anderson, L.E.; Wiltbank, M.C.; Townson, D.H. 2001: Actions of prostaglandin F2alpha and prolactin on intercellular adhesion molecule-1 expression and monocyte/macrophage accumulation in the rat corpus luteum. Biology of Reproduction 64(3): 890-897
Kan, K.K.W.; Jones, R.L.; Ngan, M-Pui.; Rudd, J.A. 2002: Actions of prostanoids to induce emesis and defecation in the ferret. European Journal of Pharmacology 453(2-3): 299-308
Mcgaw, I.J.; Mcmahon, B.R. 1999: Actions of putative cardioinhibitory substances on the in vivo decapod cardiovascular system. Journal of Crustacean Biology 19(3): 435-449
Wilson, B.W.; Henderson, J.D.; Coatney, E.M.; Nieberg, P.S.; Spencer, P.S. 2002: Actions of pyridostigmine and organophosphate agents on chick cells, mice, and chickens. Drug and Chemical Toxicology 25(2): 131-139
Wada-Takahashi, S.; Tamura, K. 2000: Actions of reactive oxygen species on AH/type 2 myenteric neurons in guinea pig distal colon. American Journal of Physiology. Gastrointestinal and Liver Physiology 279(5): G893-G902
Newman-Tancredi, A.; Cussac, D.; Audinot, V.; Millan, M.J. 1999: Actions of roxindole at recombinant human dopamine D2, D3 and D4 and serotonin 5-HT1A, 5-HT1B and 5-HT1D receptors. Naunyn-Schmiedeberg's Archives of Pharmacology 359(6): 447-453
Korolkiewicz, R.P.; Konstański, Z.; Rekowski, P.; Ruczyński, J.; Szyk, A.; Grzybowska, M.; Korolkiewicz, K.Z.; Petrusewicz, J. 2001: Actions of several substituted short analogues of porcine galanin on isolated rat fundus strips: a structure-activity relationship. Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 52(1): 127-136
Hainsworth, A.H.; Mcnaughton, N.C.L.; Pereverzev, A.; Schneider, T.; Randall, A.D. 2003: Actions of sipatrigine, 202W92 and lamotrigine on R-type and T-type Ca2+ channel currents. European Journal of Pharmacology 467(1-3): 77-80
Tunnicliff, G. 1999: Actions of sodium valproate on the central nervous system. Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 50(3): 347-365
Rauha, J.P.; Tammela, P.; Summanen, J.; Vuorela, P.; Kahkonen, M.; Heinonen, M.; Hopia, A.; Kujala, T.; Pihlaja, K.; Tornquist, K.; Vuorela, H. 1999: Actions of some plant extracts containing flavonoids and other phenolic compounds on calcium fluxes in clonal rat pituitary GH4C1 cells. Pharmaceutical and Pharmacological Letters 9(2): 66-69
Nantwi, K.D.; Goshgarian, H.G. 2002: Actions of specific adenosine receptor A1 and A2 agonists and antagonists in recovery of phrenic motor output following upper cervical spinal cord injury in adult rats. Clinical and Experimental Pharmacology and Physiology 29(10): 915-923
Pearce, R.K.; Jackson, M.; Britton, D.R.; Shiosaki, K.; Jenner, P.; Marsden, C.D. 1999: Actions of the D1 agonists A-77636 and A-86929 on locomotion and dyskinesia in MPTP-treated L-dopa-primed common marmosets. Psychopharmacology 142(1): 51-60
Asghar, A.U.; Hasan, S.S.; King, A.E. 2000: Actions of the anticonvulsant remacemide metabolite AR-R12495AA on afferent-evoked spinal synaptic transmission in vitro and on models of acute and chronic inflammation in the rat. Journal of Pharmacology and Experimental Therapeutics 294(3): 876-883
Waldeck, K.; Larsson, B.; Sandberg, B.; Andersson, K.-E. 2002: Actions of the new antimuscarinic compound Lu 25-109 on isolated human and pig detrusor. Neurourology and Urodynamics 21(1): 92-98
Ishikawa, Y.; Takagi, Y.; Takeno, H.; Watanabe, K.; Tani, T. 1998: Actions of the novel oral antidiabetic agent HQL-975 in genetically obese diabetic db/db mice. Biological and Pharmaceutical Bulletin 21(9): 928-933
Ganeshaguru, K.; Wickremasinghe, R.G.; Jones, D.T.; Gordon, M.; Hart, S.M.; Virchis, A.E.; Prentice, H.Grant.; Hoffbrand, A.Victor.; Man, A.; Champain, K.; Csermak, K.; Mehta, A.B. 2002: Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro. Haematologica 87(2): 167-176
Caputi, L.; Hainsworth, A.; Guatteo, E.; Tozzi, A.; Stefani, A.; Spadoni, F.; Leach, M.; Bernardi, G.; Mercuri, N.B. 2003: Actions of the sodium channel inhibitor 202W92 on rat midbrain dopaminergic neurons. Synapse 48(3): 123-130
Binns, K.E.; Salt, T.E. 2001: Actions of the systemically active metabotropic glutamate antagonist MPEP on sensory responses of thalamic neurones. Neuropharmacology 40(5): 639-644
Jin, Y.; Lu, Q-Min.; Wang, W-Yu.; Xiong, Y-Liang. 2002: Actions of two serine proteases from Trimeresurus jerdonii venom on chromogenic substrates and fibrinogen. Comparative Biochemistry and Physiology. Part B Biochemistry and Molecular Biology 132(3): 529-534
Hinson, J.P.; Puddefoot, J.R.; Kapas, S. 1999: Actions of vasoactive intestinal peptide on the rat adrenal zona glomerulosa. Journal of Endocrinology 161(1): 51-57
Qin Qilian; Wang Fanghai; Gong He 1999: Actions on teratocytes in coordinating the relationship between a parasitioid and its host: An overview. Acta Entomologica Sinica 42(4): 431-438
Johnson-Frey, S.H.; Maloof, F.R.; Newman-Norlund, R.; Farrer, C.; Inati, S.; Grafton, S.T. 2003: Actions or hand-object interactions? Human inferior frontal cortex and action observation. Neuron 39(6): 1053-1058
Brusasco, V.; Crimi, E.; Gherson, G.; Nardelli, R.; Oldani, V.; Francucci, B.; Della Cioppa, G.; Senn, S.; Fabbri, L.M. 2002: Actions other than smooth muscle relaxation may play a role in the protective effects of formoterol on the allergen-induced late asthmatic reaction. Pulmonary Pharmacology and Therapeutics 15(4): 399-406
Barron-Rivera, A.-Jorge; Palma-Chan, A.-Gonzalo; Juarez-Huerta, L. 2000: Actitud del medico familiar ante el paciente con VIH/sida. Factores relacionados. Revista Medica del Instituto Mexicano del Seguro Social 38(3): 203-209
Guijarro-Escribano, J.F.; Moratinos-Palomero, P.; Gutierrez-Ortega, C.; Sainz-Gonzalez, F. 2001: Actitudes en el habito del tabaco, la bebida y la actividad fisica en un contingente espanol desplazado a zona de operaciones en Bosnia-Herzegovina. Revue Internationale des Services de Sante des Forces Armees 74(3): 136-140
Sandin, B.; Chorot, P.; Valiente, R.M.; Lostao, L.; Santed, M.A.; Fernandez, O. 2000: Actitudes hipocondriacas en mujeres antes y despues de participar en pruebas complementarias de deteccion de cancer de mama. Psiquis 21(5): 20-28
Qian, Q.; Chai, Z.; Feng, W.; Chen, J.; Zhang, P.; Pan, J. 2002: Activable enriched stable isotope iron-58 for monitoring absorption rate of juvenile athletes for iron: a case study. Food and Nutrition Bulletin 23(3 Suppl): 57-60
Ott, C.M.; Smith, B.D.; Portis, A.R.; Spreitzer, R.J. 2000: Activase region on chloroplast ribulose-1,5-bisphosphate carboxylase/oxygenase. Nonconservative substitution in the large subunit alters species specificity of protein interaction. Journal of Biological Chemistry 275(34): 26241-26244
Cox, M.E.; Deeble, P.D.; Bissonette, E.A.; Parsons, S.J. 2000: Activated 3',5'-cyclic AMP-dependent protein kinase is sufficient to induce neuroendocrine-like differentiation of the LNCaP prostate tumor cell line. Journal of Biological Chemistry 275(18): 13812-13818
Fucini, R.V.; Navarrete, A.; Vadakkan, C.; Lacomis, L.; Erdjument-Bromage, H.; Tempst, P.; Stamnes, M. 2000: Activated ADP-ribosylation factor assembles distinct pools of actin on golgi membranes. Journal of Biological Chemistry 275(25): 18824-18829
Rathmell, J.C.; Elstrom, R.L.; Cinalli, R.M.; Thompson, C.B. 2003: Activated Akt promotes increased resting T cell size, CD28-independent T cell growth, and development of autoimmunity and lymphoma. European Journal of Immunology 33(8): 2223-2232
Lu, Y.; Parkyn, L.; Otterbein, L.E.; Kureishi, Y.; Walsh, K.; Ray, A.; Ray, P. 2001: Activated Akt protects the lung from oxidant-induced injury and delays death of mice. Journal of Experimental Medicine 193(4): 545-549
Loureiro, J.J.; Akong, K.; Cayirlioglu, P.; Baltus, A.E.; DiAntonio, A.; Peifer, M. 2001: Activated armadillo/beta-catenin does not play a general role in cell migration and process extension in Drosophila. Developmental Biology 235(1): 33-44
Ferszt, R.; Severus, E.; Bode, L.; Brehm, M.; Kühl K-P; Berzewski, H.; Ludwig, H. 1999: Activated Borna disease virus in affective disorders. Pharmacopsychiatry 32(3): 93-98
Hsu, H.C.; Shi, J.; Yang, P.; Xu, X.; Dodd, C.; Matsuki, Y.; Zhang, H.G.; Mountz, J.D. 2001: Activated CD8(+) T cells from aged mice exhibit decreased activation-induced cell death. Mechanisms of Ageing and Development 122(15): 1663-1684
Buckle, G.J.; Höllsberg, P.; Hafler, D.A. 2003: Activated CD8+ T cells in secondary progressive MS secrete lymphotoxin. Neurology 60(4): 702-705
Wirths, S.; Reichert, J.; Grünebach, F.; Brossart, P. 2002: Activated CD8+ T lymphocytes induce differentiation of monocytes to dendritic cells and restore the stimulatory capacity of interleukin 10-treated antigen-presenting cells. Cancer Research 62(17): 5065-5068
Roshan, B.; Kjelsberg, C.; Spokes, K.; Eldred, A.; Crovello, C.S.; Cantley, L.G. 1999: Activated ERK2 interacts with and phosphorylates the docking protein GAB1. Journal of Biological Chemistry 274(51): 36362-36368
Kim, J.; Feldman, R.A. 2002: Activated Fes protein tyrosine kinase induces terminal macrophage differentiation of myeloid progenitors (U937 cells) and activation of the transcription factor PU.1. Molecular and Cellular Biology 22(6): 1903-1918
Nakamura, T.; Yamashita, H.; Takahashi, T.; Nakamura, S. 2001: Activated Fyn phosphorylates alpha-synuclein at tyrosine residue 125. Biochemical and Biophysical Research Communications 280(4): 1085-1092
Sellers, L.A.; Feniuk, W.; Humphrey, P.P.; Lauder, H. 1999: Activated G protein-coupled receptor induces tyrosine phosphorylation of STAT3 and agonist-selective serine phosphorylation via sustained stimulation of mitogen-activated protein kinase. Resultant effects on cell proliferation. Journal of Biological Chemistry 274(23): 16423-16430
Srinivasan, J.; Gundersen, R.E.; Hadwiger, J.A. 1999: Activated Galpha subunits can inhibit multiple signal transduction pathways during Dictyostelium development. Developmental Biology 215(2): 443-452
Dutt, P.; Kjoller, L.; Giel, M.; Hall, A.; Toksoz, D. 2002: Activated Galphaq family members induce Rho GTPase activation and Rho-dependent actin filament assembly. Febs Letters 531(3): 565-569
van Kampen, C.A.; Roelen, D.L.; Versteeg-van der Voort Maarschalk, M.F.J.; Hoitsma, A.J.; Allebes, W.A.; Claas, F.H.J. 2002: Activated HLA class I-reactive cytotoxic T lymphocytes associated with a positive historical crossmatch predict early graft failure. Transplantation 74(8): 1114-1119
Navarro, P.; Valverde, A.M.; Benito, M.; Lorenzo, M. 1999: Activated Ha-ras induces apoptosis by association with phosphorylated Bcl-2 in a mitogen-activated protein kinase-independent manner. Journal of Biological Chemistry 274(27): 18857-18863
Phelan, D.R.; Price, G.; Liu, Y.F.; Dorow, D.S. 2001: Activated JNK phosphorylates the c-terminal domain of MLK2 that is required for MLK2-induced apoptosis. Journal of Biological Chemistry 276(14): 10801-10810
Niv, H.; Gutman, O.; Kloog, Y.; Henis, Y.I. 2002: Activated K-Ras and H-Ras display different interactions with saturable nonraft sites at the surface of live cells. Journal of Cell Biology 157(5): 865-872
Schramm, K.; Krause, K.; Bittroff-Leben, A.; Goldin-Lang, P.; Thiel, E.; Kreuser, E.D. 2000: Activated K-ras is involved in regulation of integrin expression in human colon carcinoma cells. International Journal of Cancer 87(2): 155-164
Okumura, K.; Shirasawa, S.; Nishioka, M.; Sasazuki, T. 1999: Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells. Cancer Research 59(10): 2445-2450
Santella, L.; Ercolano, E.; Lim, D.; Nusco, G.A.; Moccia, F. 2003: Activated M-phase-promoting factor (MPF) is exported from the nucleus of starfish oocytes to increase the sensitivity of the Ins(1,4,5)P3 receptors. Biochemical Society Transactions 31(Part 1): 79-82
Perry, R.L.; Parker, M.H.; Rudnicki, M.A. 2001: Activated MEK1 binds the nuclear MyoD transcriptional complex to repress transactivation. Molecular Cell 8(2): 291-301
Nicol, R.L.; Frey, N.; Pearson, G.; Cobb, M.; Richardson, J.; Olson, E.N. 2001: Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy. EMBO Journal 20(11): 2757-2767
Zeytinoglu, H.; Griffiths, S.L.; Gibson, I. 2002: Activated N-ras oncogene inhibits the expression of PDGF-beta receptor in myoblast cells. Eksperimental'naya Onkologiya 24(2): 116-119
Wilson-Rawls, J.; Molkentin, J.D.; Black, B.L.; Olson, E.N. 1999: Activated notch inhibits myogenic activity of the MADS-Box transcription factor myocyte enhancer factor 2C. Molecular and Cellular Biology 19(4): 2853-2862
Höfelmayr, H.; Strobl, L.J.; Marschall, G.; Bornkamm, G.W.; Zimber-Strobl, U. 2001: Activated Notch1 can transiently substitute for EBNA2 in the maintenance of proliferation of LMP1-expressing immortalized B cells. Journal of Virology 75(5): 2033-2040
Nair, P.; Somasundaram, K.; Krishna, S. 2003: Activated Notch1 inhibits p53-induced apoptosis and sustains transformation by human papillomavirus type 16 E6 and E7 oncogenes through a PI3K-PKB/Akt-dependent pathway. Journal of Virology 77(12): 7106-7112
Strobl, L.J.; Höfelmayr, H.; Marschall, G.; Brielmeier, M.; Bornkamm, G.W.; Zimber-Strobl, U. 2000: Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2. Journal of Virology 74(4): 1727-1735
Jundt, F.; Anagnostopoulos, I.; Förster, R.; Mathas, S.; Stein, H.; Dörken, B. 2002: Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma. Blood 99(9): 3398-3403
Solecki, D.J.; Liu, X.L.; Tomoda, T.; Fang, Y.; Hatten, M.E. 2001: Activated Notch2 signaling inhibits differentiation of cerebellar granule neuron precursors by maintaining proliferation. Neuron 31(4): 557-568
Qu, J.; Cammarano, M.S.; Shi, Q.; Ha, K.C.; de Lanerolle, P.; Minden, A. 2001: Activated PAK4 regulates cell adhesion and anchorage-independent growth. Molecular and Cellular Biology 21(10): 3523-3533
Borsiczky, Bázs.; Szabó, Z.; Jaberansari, M.T.; Mack, P.P.O.; Röth, E. 2003: Activated PMNs lead to oxidative stress on chondrocytes: a study of swine knees. Acta Orthopaedica Scandinavica 74(2): 190-195
Mohri, T.; Adachi, Y.; Ikehara, S.; Hioki, K.; Tokunaga, R.; Taketani, S. 1999: Activated Rac1 selectively up-regulates the expression of integrin alpha6beta4 and induces cell adhesion and membrane ruffles of nonadherent colon cancer Colo201 cells. Experimental Cell Research 253(2): 533-540
Dorman, C.M.; Johnson, S.E. 2000: Activated Raf inhibits myogenesis through a mechanism independent of activator protein 1-mediated myoblast transformation. Journal of Biological Chemistry 275(35): 27481-27487
Winter, B.; Arnold, H.H. 2000: Activated raf kinase inhibits muscle cell differentiation through a MEF2-dependent mechanism. Journal of Cell Science 113 Pt 23: 4211-4220
Varghese, H.J.; Davidson, M.T.M.; MacDonald, I.C.; Wilson, S.M.; Nadkarni, K.V.; Groom, A.C.; Chambers, A.F. 2002: Activated ras regulates the proliferation/apoptosis balance and early survival of developing micrometastases. Cancer Research 62(3): 887-891
Shaw, A.C.; Swat, W.; Ferrini, R.; Davidson, L.; Alt, F.W. 1999: Activated Ras signals developmental progression of recombinase-activating gene (RAG)-deficient pro-B lymphocytes. Journal of Experimental Medicine 189(1): 123-129
Nakashima, O.; Terada, Y.; Hanada, S.; Yamamoto, K.; Kuwahara, M.; Sasaki, S.; Marumo, F. 2000: Activated STAT1 suppresses proliferation of cultured rat mesangial cells. Kidney International 57(6): 2249-2257
Henze, M.; Gujer, W.; Mino, T.; Matsuo, T.; Wentzel, M.C.; Marais, G.V.R.; Van Loosdrecht, M.C.M. 1999: Activated Sludge Model No. 2d, ASM2d. Water Science and Technology 39(1): 165-182
Gujer, W.; Henze, M.; Mino, T.; Van Loosdrecht, M. 1999: Activated Sludge Model No. 3. Water Science and Technology 39(1): 183-193
Zou, J.X.; Liu, Y.; Pasquale, E.B.; Ruoslahti, E. 2002: Activated SRC oncogene phosphorylates R-ras and suppresses integrin activity. Journal of Biological Chemistry 277(3): 1824-1827
Hildeman, D.A.; Zhu, Y.; Mitchell, T.C.; Bouillet, P.; Strasser, A.; Kappler, J.; Marrack, P. 2002: Activated T cell death in vivo mediated by proapoptotic Bcl-2 family member Bim. Immunity 16(6): 759-767
Ariki, N.; Morimoto, Y.; Yagi, T.; Oyama, T.; Cyouda, Y.; Sadamori, H.; Inagaki, M.; Urushihara, N.; Iwagaki, H.; Tanaka, N. 2003: Activated T cells and soluble molecules in the portal venous blood of patients with cholestatic and hepatitis C virus-positive liver cirrhosis. Possible promotion of Fas/FasL-mediated apoptosis in the bile-duct cells and hepatocyte injury. Journal of International Medical Research 31(3): 170-180
Bode, U.; Duda, C.; Weidner, F.; Rodriguez-Palmero, M.; Wonigeit, K.; Pabst, R.; Westermann, J. 1999: Activated T cells enter rat lymph nodes and Peyer's patches via high endothelial venules: survival by tissue-specific proliferation and preferential exit of CD8+ T cell progeny. European Journal of Immunology 29(5): 1487-1495
Ivarsson, M.; Lundin, B.S.; Lundberg, C. 2002: Activated T cells in the surface secretion on the adenoid--a flow cytometric study. Scandinavian Journal of Immunology 56(3): 310-314
Tan, K.H.; Purcell, W.M.; Heales, S.J.R.; McLeod, J.D.; Hurst, R.D. 2002: Activated T cells mediate direct blood-brain barrier endothelial cell death and dysfunction. Neuroreport 13(18): 2587-2591
Krüger, K.; Büning, C.; Schriever, F. 2001: Activated T lymphocytes bind in situ to stromal tissue of colon carcinoma but lack adhesion to tumor cells. European Journal of Immunology 31(1): 138-145
Krabbe, K.S.; Bruunsgaard, H.; Qvist, J.; Fonsmark, L.; Møller, K.; Hansen, C.M.; Skinhøj, P.; Pedersen, B.K. 2002: Activated T lymphocytes disappear from circulation during endotoxemia in humans. Clinical and Diagnostic Laboratory Immunology 9(3): 731-735
Tchórzewski, H.; Głowacka, E.; Banasik, M.; Lewkowicz, P.; Szałapska-Zawodniak, M. 2001: Activated T lymphocytes from patients with high risk of type I diabetes mellitus have different ability to produce interferon-gamma, interleukin-6 and interleukin-10 and undergo anti-CD95 induced apoptosis after insulin stimulation. Immunology Letters 75(3): 225-234
Horwood, N.J.; Kartsogiannis, V.; Quinn, J.M.; Romas, E.; Martin, T.J.; Gillespie, M.T. 1999: Activated T lymphocytes support osteoclast formation in vitro. Biochemical and Biophysical Research Communications 265(1): 144-150
Lum, L.G.; Sen, M. 2001: Activated T-cell and bispecific antibody immunotherapy for high-risk breast cancer. Bench to bedside. Acta Haematologica 105(3): 130-136
Alexander, J.S.; Dayton, T.; Davis, C.; Hill, S.; Jackson, T.H.; Blaschuk, O.; Symonds, M.; Okayama, N.; Kevil, C.G.; Laroux, F.S.; Berney, S.M.; Kimpel, D. 1998: Activated T-lymphocytes express occludin, a component of tight junctions. Inflammation 22(6): 573-582
Zhang-Qin; Hu-Hai-Feng; Zhu-Bao-Quan; Gong-Bing-Yong; Ochi, K. 2002: Activated actinorhodin production in Streptomyces lividans 66 by inducing rifampicin-resistant mutations. Zhongguo Kangshengsu Zazhi 27(11): 651-652, 687
Fabrizi, C.; Businaro, R.; Lauro, G.M.; Starace, G.; Fumagalli, L. 1999: Activated alpha2macroglobulin increases beta-amyloid (25-35)-induced toxicity in LAN5 human neuroblastoma cells. Experimental Neurology 155(2): 252-259
Wu, C.; Singh, S.K.; Dias, P.; Kumar, S.; Mann, D.M. 1999: Activated astrocytes display increased 5-HT2a receptor expression in pathological states. Experimental Neurology 158(2): 529-533
Ferraguti, F.; Corti, C.; Valerio, E.; Mion, S.; Xuereb, J. 2001: Activated astrocytes in areas of kainate-induced neuronal injury upregulate the expression of the metabotropic glutamate receptors 2/3 and 5. Experimental Brain Research 137(1): 1-11
Kajihara, H.; Tsutsumi, E.; Kinoshita, A.; Nakano, J.; Takagi, K.; Takeo, S. 2001: Activated astrocytes with glycogen accumulation in ischemic penumbra during the early stage of brain infarction: Immunohistochemical and electron microscopic studies. Brain Research 909(1-2): 92-101
Bain, G.; Müller, T.; Wang, X.; Papkoff, J. 2003: Activated beta-catenin induces osteoblast differentiation of C3H10T1/2 cells and participates in BMP2 mediated signal transduction. Biochemical and Biophysical Research Communications 301(1): 84-91
Echarri, A.; Pendergast, A.M. 2001: Activated c-Abl is degraded by the ubiquitin-dependent proteasome pathway. Current Biology: Cb 11(22): 1759-1765
Maulik, G.; Madhiwala, P.; Brooks, S.; Ma, P.C.; Kijima, T.; Tibaldi, E.V.; Schaefer, E.; Parmar, K.; Salgia, R. 2002: Activated c-Met signals through PI3K with dramatic effects on cytoskeletal functions in small cell lung cancer. Journal of Cellular and Molecular Medicine 6(4): 539-553
Mitsuda, N.; Ohkubo, N.; Tamatani, M.; Lee, Y.D.; Taniguchi, M.; Namikawa, K.; Kiyama, H.; Yamaguchi, A.; Sato, N.; Sakata, K.; Ogihara, T.; Vitek, M.P.; Tohyama, M. 2001: Activated cAMP-response element-binding protein regulates neuronal expression of presenilin-1. Journal of Biological Chemistry 276(13): 9688-9698
Beler-Baykal, B.; Witte, G.; Sekoulov, I. 2002: Activated carbon and residual nitrification for higher quality effluents for the coastal areas. Water Science and Technology: a Journal of the International Association on Water Pollution Research 46(8): 99-104
Okada, M.; Morinaga, H.; Nishijima, W. 2000: Activated carbon as a better habitat for water and wastewater treatment microorganisms. Water Science and Technology 42(12): 149-154
Van Der Zee, F.P.; Bisschops, I.A.E.; Lettinga, G.; Field, J.A. 2003: Activated carbon as an electron acceptor and redox mediator during the anaerobic biotransformation of azo dyes. Environmental Science and Technology 37(2): 402-408
Bacaoui, A.; Yaacoubi, A.; Dahbi, A.; Bennouna, C.; Ayele, J.; Mazet, M. 1998: Activated carbon production from Moroccan olive wastes: Influence of some factors. Environmental Technology 19(12): 1203-1212
Mohamed, Z.A.; Carmichael, W.W.; An, J.; El-Sharouny, H.M. 1999: Activated carbon removal efficiency of microcystins in an aqueous cell extract of Microcystis aeruginosa and Oscillatoria tenuis strains isolated from Egyptian freshwaters. Environmental Toxicology 14(1): 197-201
Rivera-Utrilla, J.; Bautista-Toledo, I.; Ferro-Garcia, M.A.; Moreno-Castilla, C. 2001: Activated carbon surface modifications by adsorption of bacteria and their effect on aqueous lead adsorption. Journal of Chemical Technology and Biotechnology 76(12): 1209-1215
Lasley, R.D.; Narayan, P.; Uittenbogaard, A.; Smart, E.J. 2000: Activated cardiac adenosine A(1) receptors translocate out of caveolae. Journal of Biological Chemistry 275(6): 4417-4421
Daemen, M.A.; Denecker, G.; van't Veer, C.; Wolfs, T.G.; Vandenabeele, P.; Buurman, W.A. 2001: Activated caspase-1 is not a central mediator of inflammation in the course of ischemia-reperfusion. Transplantation 71(6): 778-784
Su, J.H.; Zhao, M.; Anderson, A.J.; Srinivasan, A.; Cotman, C.W. 2001: Activated caspase-3 expression in Alzheimer's and aged control brain: Correlation with Alzheimer pathology. Brain Research 898(2): 350-357
Lapatto-Reiniluoto, O.; Kivistö, K.T.; Neuvonen, P.J. 2001: Activated charcoal alone and followed by whole-bowel irrigation in preventing the absorption of sustained-release drugs. Clinical Pharmacology and Therapeutics 70(3): 255-260
Christophersen, A.B.; Levin, D.; Hoegberg, L.C.G.; Angelo, H.R.; Kampmann, J.P. 2002: Activated charcoal alone or after gastric lavage: A simulated large paracetamol intoxication. British Journal of Clinical Pharmacology 53(3): 312-317
Gades, N.M.; Chyka, P.A.; Butler, A.Y.; Virgous, C.K.; Mandrell, T.D. 2003: Activated charcoal and the absorption of ferrous sulfate in rats. Veterinary and Human Toxicology 45(4): 183-187
Dasgupta, A.; Cao, S.; Wells, A. 2003: Activated charcoal is effective but equilibrium dialysis is ineffective in removing oleander leaf extract and oleandrin from human serum: monitoring the effect by measuring apparent digoxin concentration. Therapeutic Drug Monitoring 25(3): 323-330
Dasgupta, A.; Wahed, A.; Culton, L.; Olsen, M.; Wells, A.; Actor, J.K. 2002: Activated charcoal is more effective than equilibrium dialysis in removing Chinese medicines Chan Su and Dan Shen from serum and activated charcoal also prevents further absorption of these agents from G.I. tract in mice: Monitoring the effect in clinical laboratory by measuring digoxin activity in serum. Clinica Chimica Acta; International Journal of Clinical Chemistry 324(1-2): 51-59
Buckley, N.A.; Whyte, I.M.; O'Connell, D.L.; Dawson, A.H. 1999: Activated charcoal reduces the need for N-acetylcysteine treatment after acetaminophen (paracetamol) overdose. Journal of Toxicology. Clinical Toxicology 37(6): 753-757
Fountain, J.S.; Beasley, D.M. 1998: Activated charcoal supercedes ipecac as gastric decontaminant. New Zealand Medical Journal 111(1076): 402-404
Kumar, C.G.; Parrack, P. 2003: Activated charcoal: A versatile decolorization agent for the recovery and purification of alkaline protease. World Journal of Microbiology and Biotechnology 19(3): 243-246
Cetrulo, G.L.; Hay, M.E. 2000: Activated chemical defenses in tropical versus temperate seaweeds. Marine Ecology Progress Series 207: 243-253
Kobayashi, H.; Kawamoto, S.; Star, R.A.; Waldmann, T.A.; Brechbiel, M.W.; Choyke, P.L. 2003: Activated clearance of a biotinylated macromolecular MRi contrast agent from the blood pool using an avidin chase. Bioconjugate Chemistry 14(5): 1044-1047
Monno, R.; Grandaliano, G.; Faccio, R.; Ranieri, E.; Martino, C.; Gesualdo, L.; Schena, F.P. 2001: Activated coagulation factor X: a novel mitogenic stimulus for human mesangial cells. Journal of the American Society of Nephrology: Jasn 12(5): 891-899
Van Alstyne, K.L.; Wolfe, G.V.; Freidenburg, T.L.; Neill, A.; Hicken, C. 2001: Activated defense systems in marine macroalgae: Evidence for an ecological role for DMSP cleavage. Marine Ecology Progress Series 213: 53-65
Fujii, S.; Hamada, H.; Fujimoto, K.; Shimomura, T.; Kawakita, M. 1999: Activated dendritic cells from bone marrow cells of mice receiving cytokine-expressing tumor cells are associated with the enhanced survival of mice bearing syngeneic tumors. Blood 93(12): 4328-4335
Friesen, C.A.; Andre, L.; Garola, R.; Hodge, C.; Roberts, C. 2002: Activated duodenal mucosal eosinophils in children with dyspepsia: a pilot transmission electron microscopic study. Journal of Pediatric Gastroenterology and Nutrition 35(3): 329-333
Daneshpouy, M.; Socie, G.; Lemann, M.; Rivet, J.; Gluckman, E.; Janin, A. 2002: Activated eosinophils in upper gastrointestinal tract of patients with graft-versus-host disease. Blood 99(8): 3033-3040
Furbert-Harris, P.M.; Laniyan, I.; Harris, D.; Dunston, G.M.; Vaughn, T.; Abdelnaby, A.; Parish-Gause, D.; Oredipe, O.A. 2003: Activated eosinophils infiltrate MCF-7 breast multicellular tumor spheroids. Anticancer Research 23(1a): 71-78
Albanell, J.; Codony-Servat, J.; Rojo, F.; Del Campo, J.M.; Sauleda, S.; Anido, J.; Raspall, G.; Giralt, J.; Roselló, J.; Nicholson, R.I.; Mendelsohn, J.; Baselga, J. 2001: Activated extracellular signal-regulated kinases: association with epidermal growth factor receptor/transforming growth factor alpha expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments. Cancer Research 61(17): 6500-6510
Mclaren, M.; Alkaabi, J.; Connacher, M.; Belch, J.J.F.; Valenete, E. 2002: Activated factor XII in rheumatoid arthritis. Rheumatology International 22(5): 182-184
Colhoun, H.M.; Zito, F.; Norman Chan, N.; Rubens, M.B.; Fuller, J.H.; Humphries, S.E. 2002: Activated factor XII levels and factor XII 46C>T genotype in relation to coronary artery calcification in patients with type 1 diabetes and healthy subjects. Atherosclerosis 163(2): 363-369
Ishii, K.; Oguchi, S.; Murata, M.; Mitsuyoshi, Y.; Takeshita, E.; Ito, D.; Tanahashi, N.; Fukuuchi, Y.; Oosumi, K.; Matsumoto, K.; Kitajima, M.; Yamamoto, M.; Watanabe, G.; Ikeda, Y.; Watanabe, K. 2000: Activated factor XIi levels are dependent on factor XIi 46C/T genotypes and factor XIi zymogen levels, and are associated with vascular risk factors in patients and healthy subjects. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 11(3): 277-284
Chesi, M.; Brents, L.A.; Ely, S.A.; Bais, C.; Robbiani, D.F.; Mesri, E.A.; Kuehl, W.M.; Bergsagel, P.L. 2001: Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma. Blood 97(3): 729-736
Yin, H.; Wang, L.; Huo, Y.; Peng, X.; Xia, C.; Tang, C. 2002: Activated focal adhesion kinase involved in adhesion and migration of vascular smooth muscle cells stimulated by fibronectin. Chinese Medical Journal 115(4): 494-497
Schmielau, J.; Finn, O.J. 2001: Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients. Cancer Research 61(12): 4756-4760
Lin, C-Ming.; Wang, F-Hwei.; Lee, P-Kung. 2002: Activated human CD4+ T cells induced by dendritic cell stimulation are most sensitive to transforming growth factor-beta: implications for dendritic cell immunization against cancer. Clinical Immunology 102(1): 96-105
Holling, T.M.; van der Stoep, N.; Quinten, E.; van den Elsen, P.J. 2002: Activated human T cells accomplish MHC class Ii expression through T cell-specific occupation of class Ii transactivator promoter IIi. Journal of Immunology 168(2): 763-770
Kotake, S.; Udagawa, N.; Hakoda, M.; Mogi, M.; Yano, K.; Tsuda, E.; Takahashi, K.; Furuya, T.; Ishiyama, S.; Kim, K.J.; Saito, S.; Nishikawa, T.; Takahashi, N.; Togari, A.; Tomatsu, T.; Suda, T.; Kamatani, N. 2001: Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients. Arthritis and Rheumatism 44(5): 1003-1012
Kerschensteiner, M.; Gallmeier, E.; Behrens, L.; Leal, V.V.; Misgeld, T.; Klinkert, W.E.; Kolbeck, R.; Hoppe, E.; Oropeza-Wekerle, R.L.; Bartke, I.; Stadelmann, C.; Lassmann, H.; Wekerle, H.; Hohlfeld, R. 1999: Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: A neuroprotective role of inflammation?. Journal of Experimental Medicine 189(5): 865-870
Close, A.H.; Guo, T.L.; Shenker, B.J. 1999: Activated human T lymphocytes exhibit reduced susceptibility to methylmercury chloride-induced apoptosis. Toxicological Sciences: An Official Journal of the Society of Toxicology 49(1): 68-77
Novak, E.J.; Masewicz, S.A.; Liu, A.W.; Lernmark, A.; Kwok, W.W.; Nepom, G.T. 2001: Activated human epitope-specific T cells identified by class Ii tetramers reside within a CD4high, proliferating subset. International Immunology 13(6): 799-806
Bataller, Rón.; Sancho-Bru, P.; Ginès, P.; Lora, Jé.M.; Al-Garawi, A.; Solé, M.; Colmenero, J.; Nicolás, J.M.; Jiménez, W.; Weich, N.; Gutiérrez-Ramos, Jé-Carlos.; Arroyo, V.; Rodés, J. 2003: Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II. Gastroenterology 125(1): 117-125
Ahmad, R.; Menezes, J.; Knafo, L.; Ahmad, A. 2001: Activated human platelets express Fas-L and induce apoptosis in Fas-positive tumor cells. Journal of Leukocyte Biology 69(1): 123-128
Leblhuber, F.; Walli, J.; Jellinger, K.; Tilz, G.P.; Widner, B.; Laccone, F.; Fuchs, D. 1998: Activated immune system in patients with Huntington's disease. Clinical Chemistry and Laboratory Medicine 36(10): 747-750
Chaib, H.; Rubin, M.A.; Mucci, N.R.; Li, L.; Taylor JMG; Day, M.L.; Rhim, J.S.; Macoska, J.A. 2001: Activated in prostate cancer: a PDZ domain-containing protein highly expressed in human primary prostate tumors. Cancer Research 61(6): 2390-2394
Rolli, M.; Fransvea, E.; Pilch, J.; Saven, A.; Felding-Habermann, B. 2003: Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America 100(16): 9482-9487
Rabkin, E.; Aikawa, M.; Stone, J.R.; Fukumoto, Y.; Libby, P.; Schoen, F.J. 2001: Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation 104(21): 2525-2532
Kimura, K.; Kakimi, K.; Wieland, S.; Guidotti, L.G.; Chisari, F.V. 2002: Activated intrahepatic antigen-presenting cells inhibit hepatitis B virus replication in the liver of transgenic mice. Journal of Immunology 169(9): 5188-5195
Strehlau, J.; Schachter, A.D.; Pavlakis, M.; Singh, A.; Tejani, A.; Strom, T.B. 2002: Activated intrarenal transcription of CTL-effectors and TGF-beta1 in children with focal segmental glomerulosclerosis. Kidney International 61(1): 90-95
Deb, S.; Zhang, J.W.; Gottschall, P.E. 1999: Activated isoforms of MMP-2 are induced in U87 human glioma cells in response to beta-amyloid peptide. Journal of Neuroscience Research 55(1): 44-53
Ohta, T.; Tajima, H.; Yachie, A.; Yokoyama, K.; Elnemr, A.; Fushida, S.; Kitagawa, H.; Kayahara, M.; Nishimura, G.; Miwa, K.; Yamamoto, M.; Terada, T.; Ohkuma, S. 1999: Activated lansoprazole inhibits cancer cell adhesion to extracellular matrix components. International Journal of Oncology 15(1): 33-39
Swart, G.W.M. 2002: Activated leukocyte cell adhesion molecule (CD166/ALCAM): developmental and mechanistic aspects of cell clustering and cell migration. European Journal of Cell Biology 81(6): 313-321
Van Kempen, L.C.; van den Oord, J.J.; van Muijen, G.N.; Weidle, U.H.; Bloemers, H.P.; Swart, G.W. 2000: Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin. American Journal of Pathology 156(3): 769-774
Batchelor, P.E.; Liberatore, G.T.; Wong, J.Y.; Porritt, M.J.; Frerichs, F.; Donnan, G.A.; Howells, D.W. 1999: Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 19(5): 1708-1716
Frenkel, O.; Shani, E.; Ben-Bassat, I.; Brok-Simoni, F.; Rozenfeld-Granot, G.; Kajakaro, G.; Rechavi, G.; Amariglio, N.; Shinar, E.; Danon, D. 2002: Activated macrophages for treating skin ulceration: Gene expression in human monocytes after hypo-osmotic shock. Clinical and Experimental Immunology 128(1): 59-66
Griffon, B.; Cillard, J.; Chevanne, M.; Morel, I.; Cillard, P.; Sergent, O. 2000: Activated macrophages increase the susceptibility of rat hepatocytes to ethanol-induced oxidative stress: conflicting effects of nitric oxide. Alcohol and Alcoholism 35(3): 230-235
Kenerson, H.L.; Aicher, L.D.; True, L.D.; Yeung, R.S. 2002: Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors. Cancer Research 62(20): 5645-5650
Metsärinne, K.P.; Vehmaan-Kreula, P.; Kovanen, P.T.; Saijonmaa, O.; Baumann, M.; Wang, Y.; Nyman, T.; Fyhrquist, F.Y.; Eklund, K.K. 2002: Activated mast cells increase the level of endothelin-1 mRNA in cocultured endothelial cells and degrade the secreted Peptide. Arteriosclerosis Thrombosis and Vascular Biology 22(2): 268-273
Park, C.H.; Joo, Y.E.; Choi, S.K.; Rew, J.S.; Kim, S.J.; Lee, M.C. 2003: Activated mast cells infiltrate in close proximity to enteric nerves in diarrhea-predominant irritable bowel syndrome. Journal of Korean Medical Science 18(2): 204-210
Mattapallil, J.J.; Smit-McBride, Z.; Dailey, P.; Dandekar, S. 1999: Activated memory CD4(+) T helper cells repopulate the intestine early following antiretroviral therapy of simian immunodeficiency virus-infected rhesus macaques but exhibit a decreased potential to produce interleukin-2. Journal of Virology 73(8): 6661-6669
Jayne, D.G.; Perry, S.L.; Morrison, E.; Farmery, S.M.; Guillou, P.J. 2000: Activated mesothelial cells produce heparin-binding growth factors: implications for tumour metastases. British Journal of Cancer 82(6): 1233-1238
He, B.Ping.; Wen, W.; Strong, M.J. 2002: Activated microglia (BV-2) facilitation of TNF-alpha-mediated motor neuron death in vitro. Journal of Neuroimmunology 128(1-2): 31-38
Ohmi, K.; Greenberg, D.S.; Rajavel, K.S.; Ryazantsev, S.; Li, H.H.; Neufeld, E.F. 2003: Activated microglia in cortex of mouse models of mucopolysaccharidoses i and IIIB. Proceedings of the National Academy of Sciences of the United States of America 100(4): 1902-1907
Mackenzie, I.R. 2000: Activated microglia in dementia with Lewy bodies. Neurology 55(1): 132-134
Gupta, N.; Brown, K.E.; Milam, A.H. 2003: Activated microglia in human retinitis pigmentosa, late-onset retinal degeneration, and age-related macular degeneration. Experimental Eye Research 76(4): 463-471
Rozemuller, A.J.; Eikelenboom, P.; Theeuwes, J.W.; Jansen Steur, E.N.; de Vos, R.A. 2000: Activated microglial cells and complement factors are unrelated to cortical Lewy bodies. Acta Neuropathologica 100(6): 701-708
Heppner, F.L.; Skutella, T.; Hailer, N.P.; Haas, D.; Nitsch, R. 1998: Activated microglial cells migrate towards sites of excitotoxic neuronal injury inside organotypic hippocampal slice cultures. European Journal of Neuroscience 10(10): 3284-3290
Abumiya, T.; Lucero, J.; Heo, J.H.; Tagaya, M.; Koziol, J.A.; Copeland, B.R.; del Zoppo, G.J. 1999: Activated microvessels express vascular endothelial growth factor and integrin alpha(v)beta3 during focal cerebral ischemia. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 19(9): 1038-1050
Belcher, J.D.; Marker, P.H.; Weber, J.P.; Hebbel, R.P.; Vercellotti, G.M. 2000: Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion. Blood 96(7): 2451-2459
Yoshida, A.; Elner, S.G.; Bian, Z-Mei.; Kindezelskii, A.L.; Petty, H.R.; Elner, V.M. 2003: Activated monocytes induce human retinal pigment epithelial cell apoptosis through caspase-3 activation. Laboratory Investigation; a Journal of Technical Methods and Pathology 83(8): 1117-1129
Seshiah, P.N.; Kereiakes, D.J.; Vasudevan, S.S.; Lopes, N.; Su, B.Y.; Flavahan, N.A.; Goldschmidt-Clermont, P.J. 2002: Activated monocytes induce smooth muscle cell death: role of macrophage colony-stimulating factor and cell contact. Circulation 105(2): 174-180
Höfelmayr, H.; Strobl, L.J.; Stein, C.; Laux, G.; Marschall, G.; Bornkamm, G.W.; Zimber-Strobl, U. 1999: Activated mouse Notch1 transactivates Epstein-Barr virus nuclear antigen 2-regulated viral promoters. Journal of Virology 73(4): 2770-2780
Dermott, J.M.; Wadsworth, S.J.; van Rossum, G.D.; Dhanasekaran, N. 2001: Activated mutant of Galpha(12) enhances the hyperosmotic stress response of NIH3T3 cells. Journal of Cellular Biochemistry 81(1): 1-8
Ribeiro, U.; Whiteside, T.L.; Basse, P.H.; Safatle-Ribeiro, A.V.; Huneke, C.E.; Posner, M.C. 1999: Activated natural killer cell tumor retention and cytokine production in colon tumor using a tissue-isolated model. Journal of Surgical Research 82(1): 78-87
Harada, N.; Okajima, K.; Liu, W.; Uchiba, M. 2000: Activated neutrophils impair gastric cytoprotection role of neutrophil elastase. Digestive Diseases and Sciences 45(6): 1210-1216
Tinsley, J.H.; Wu, M.H.; Ma, W.; Taulman, A.C.; Yuan, S.Y. 1999: Activated neutrophils induce hyperpermeability and phosphorylation of adherens junction proteins in coronary venular endothelial cells. Journal of Biological Chemistry 274(35): 24930-24934
Czapski, G.A.; Avram, D.; Sakharov, D.V.; Wirtz, K.W.A.; Strosznajder, J.B.; Pap, E.H.W. 2002: Activated neutrophils oxidize extracellular proteins of endothelial cells in culture: effect of nitric oxide donors. Biochemical Journal 365(Part 3): 897-902
Westland, K.W.; Pollard, J.D.; Sander, S.; Bonner, J.G.; Linington, C.; McLeod, J.G. 1999: Activated non-neural specific T cells open the blood-brain barrier to circulating antibodies. Brain: a Journal of Neurology 122: 1283-1291
Hippeli, S.; Heiser, I.; Elstner, E.F. 1999: Activated oxygen and free oxygen radicals in pathology: New insights and analogies between animals and plants. Plant Physiology and Biochemistry 37(3): 167-178
Calvi, L.M.; Sims, N.A.; Hunzelman, J.L.; Knight, M.C.; Giovannetti, A.; Saxton, J.M.; Kronenberg, H.M.; Baron, R.; Schipani, E. 2001: Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone. Journal of Clinical Investigation 107(3): 277-286
Rajeshwarisivaraj; Subburam, V. 2002: Activated parthenium carbon as an adsorbent for the removal of dyes and heavy metal ions from aqueous solution. Bioresource technology 85(2): 205-206
Oldgren, J.; Linder, R.; Grip, L.; Siegbahn, A.; Wallentin, L. 1999: Activated partial thromboplastin time and clinical outcome after thrombin inhibition in unstable coronary artery disease. European Heart Journal 20(22): 1657-1666
Ogasawara, M.; Aoki, K.; Katano, K.; Aoyama, T.; Ozaki, Y.; Suzumori, K. 1998: Activated partial thromboplastin time is a predictive parameter for further miscarriages in cases of recurrent fetal loss. Fertility and Sterility 70(6): 1081-1084
Imlach, S.; McBreen, S.; Shirafuji, T.; Leen, C.; Bell, J.E.; Simmonds, P. 2001: Activated peripheral CD8 lymphocytes express CD4 in vivo and are targets for infection by human immunodeficiency virus type 1. Journal of Virology 75(23): 11555-11564
Kyriakou, D.S.; Alexandrakis, M.G.; Kyriakou, E.S.; Liapi, D.; Kourelis, T.V.; Passam, F.; Papadakis, A. 2001: Activated peripheral blood and endothelial cells in thalassemia patients. Annals of Hematology 80(10): 577-583
Maekawa, H.; Iwabuchi, K.; Nagaoka, I.; Watanabe, H.; Kamano, T.; Tsurumaru, M. 2000: Activated peritoneal macrophages inhibit the proliferation of rat ascites hepatoma AH-130 cells via the production of tumor necrosis factor-alpha and nitric oxide. Inflammation Research: Official Journal of the European Histamine Research Society . 49(10): 541-547
Lee, S.W.; Lee, H.S.; Kim, E.J.; Yoo, M.A.; Lee, B.L. 2001: Activated phenoloxidase interacts with a novel glycine-rich protein on the yeast two-hybrid system. Journal of Biochemistry and Molecular Biology 34(1): 15-20
Tanaka, K.; Nogawa, S.; Ito, D.; Suzuki, S.; Dembo, T.; Kosakai, A.; Fukuuchi, Y. 2000: Activated phosphorylation of cyclic AMP response element binding protein is associated with preservation of striatal neurons after focal cerebral ischemia in the rat. Neuroscience 100(2): 345-354
Kirton, C.M.; Nash, G.B. 2000: Activated platelets adherent to an intact endothelial cell monolayer bind flowing neutrophils and enable them to transfer to the endothelial surface. Journal of Laboratory and Clinical Medicine 136(4): 303-313
Cirillo, P.; Golino, P.; Ragni, M.; Battaglia, C.; Pacifico, F.; Formisano, S.; Buono, C.; Condorelli, M.; Chiariello, M. 1999: Activated platelets and leucocytes cooperatively stimulate smooth muscle cell proliferation and proto-oncogene expression via release of soluble growth factors. Cardiovascular Research 43(1): 210-218
Danese, S.; Katz, J.A.; Saibeni, S.; Papa, A.; Gasbarrini, A.; Vecchi, M.; Fiocchi, C. 2003: Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. Gut 52(10): 1435-1441
Baird, T.R.; Walsh, P.N. 2002: Activated platelets but not endothelial cells participate in the initiation of the consolidation phase of blood coagulation. Journal of Biological Chemistry 277(32): 28498-28503
Fu, L-Wu.; Longhurst, J.C. 2002: Activated platelets contribute to stimulation of cardiac afferents during ischaemia in cats: role of 5-HT(3) receptors. Journal of Physiology 544(3): 897-912
Ogura, H.; Kawasaki, T.; Tanaka, H.; Koh, T.; Tanaka, R.; Ozeki, Y.; Hosotsubo, H.; Kuwagata, Y.; Shimazu, T.; Sugimoto, H. 2001: Activated platelets enhance microparticle formation and platelet-leukocyte interaction in severe trauma and sepsis. Journal of Trauma 50(5): 801-809
de Man, F.H.; Nieuwland, R.; van der Laarse, A.; Romijn, F.; Smelt, A.H.; Gevers Leuven, J.A.; Sturk, A. 2000: Activated platelets in patients with severe hypertriglyceridemia: Effects of triglyceride-lowering therapy. Atherosclerosis 152(2): 407-414
Cha, J.K.; Jeong, M.H.; Bae, H.R.; Han, J.Y.; Jeong, S.J.; Jin, H.J.; Lim, Y.J.; Kim, S.H.; Kim, J.W. 2000: Activated platelets induce secretion of interleukin-1beta, monocyte chemotactic protein-1, and macrophage inflammatory protein-1alpha and surface expression of intercellular adhesion molecule-1 on cultured endothelial cells. Journal of Korean Medical Science 15(3): 273-278
Shenkman, B.; Rubinstein, E.; Dardik, R.; Tamarin, I.; Savion, N.; Varon, D. 1999: Activated platelets mediate Staphylococcus aureus deposition on subendothelial extracellular matrix: the role of glycoprotein Ib. Platelets 10(1): 36-44
Lindemann, S.; Tolley, N.D.; Dixon, D.A.; McIntyre, T.M.; Prescott, S.M.; Zimmerman, G.A.; Weyrich, A.S. 2001: Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. Journal of Cell Biology 154(3): 485-490
Holada, K.; Simak, J.; Risitano, A.M.; Maciejewski, J.; Young, N.S.; Vostal, J.G. 2002: Activated platelets of patients with paroxysmal nocturnal hemoglobinuria express cellular prion protein. Blood 100(1): 341-343
Heijnen, H.F.; Schiel, A.E.; Fijnheer, R.; Geuze, H.J.; Sixma, J.J. 1999: Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 94(11): 3791-3799
Massberg, S.; Vogt, F.; Dickfeld, T.; Brand, K.; Page, S.; Gawaz, M. 2003: Activated platelets trigger an inflammatory response and enhance migration of aortic smooth muscle cells. Thrombosis Research 110(4): 187-194
Berliner, S.; Rogowski, O.; Rotstein, R.; Fusman, R.; Shapira, I.; Bornstein, N.M.; Prochorov, V.; Roth, A.; Keren, G.; Eldor, A.; Zeltser, D. 2000: Activated polymorphonuclear leukocytes and monocytes in the peripheral blood of patients with ischemic heart and brain conditions correspond to the presence of multiple risk factors for atherothrombosis. Cardiology 94(1): 19-25
Fujimi, S.; Ogura, H.; Tanaka, H.; Koh, T.; Hosotsubo, H.; Nakamori, Y.; Kuwagata, Y.; Shimazu, T.; Sugimoto, H. 2002: Activated polymorphonuclear leukocytes enhance production of leukocyte microparticles with increased adhesion molecules in patients with sepsis. Journal of Trauma 52(3): 443-448
Dun, Y.; Zhi, J.M.; Sun, H.Y.; Zhao, R.R.; Zhao, Z.Q. 2002: Activated polymorphonuclear leukocytes induce cardiomyocyte apoptosis and the protective effects of carvedilol. Methods and Findings in Experimental and Clinical Pharmacology 24(7): 403-412
Alferiev, I.S.; Fishbein, I. 2002: Activated polyurethane modified with latent thiol groups. Biomaterials 23(24): 4753-4758
Sumitran-Holgersson, S.; Brevig, T.; Widner, Håkan.; Holgersson, J. 2003: Activated porcine embryonic brain endothelial cells induce a proliferative human T-lymphocyte response. Cell Transplantation 12(6): 637-646
Karni, R.; Dor, Y.; Keshet, E.; Meyuhas, O.; Levitzki, A. 2002: Activated pp60c-Src leads to elevated hypoxia-inducible factor (HIF)-1alpha expression under normoxia. Journal of Biological Chemistry 277(45): 42919-42925
Klingler, K.R.; Grote, S.; Holzem, G.; Wielckens, K. 1999: Activated protein C (APC)-resistance: automated detection of the point mutation at position 1691 in the factor V gene. Clinical Chemistry and Laboratory Medicine 37(2): 101-107
Dömötör, E.; Benzakour, O.; Griffin, J.H.; Yule, D.; Fukudome, K.; Zlokovic, B.V. 2003: Activated protein C alters cytosolic calcium flux in human brain endothelium via binding to endothelial protein C receptor and activation of protease activated receptor-1. Blood 101(12): 4797-4801
Petäjä, J.; Pesonen, E.; Fernández, J.A.; Griffin, J.H.; Repo, H.; Jansson, S.E.; Vento, A.E.; Rämö, O.J. 2001: Activated protein C and inflammation in human myocardium after heart surgery. American Journal of Hematology 67(3): 210-212
Oliver, J.A.; Monroe, D.M.; Church, F.C.; Roberts, H.R.; Hoffman, M. 2002: Activated protein C cleaves factor Va more efficiently on endothelium than on platelet surfaces. Blood 100(2): 539-546
Hooper, W.C.; Phillips, D.J.; Renshaw, M.A. 2001: Activated protein C induction of MCP-1 in human endothelial cells: A possible role for endothelial cell nitric oxide synthase. Thrombosis Research 103(3): 209-219
Shimizu, S.; Gabazza, E.C.; Taguchi, O.; Yasui, H.; Taguchi, Y.; Hayashi, T.; Ido, M.; Shimizu, T.; Nakagaki, T.; Kobayashi, H.; Fukudome, K.; Tsuneyoshi, N.; D'Alessandro-Gabazza, C.N.; Izumizaki, M.; Iwase, M.; Homma, I.; Adachi, Y.; Suzuki, K. 2003: Activated protein C inhibits the expression of platelet-derived growth factor in the lung. American Journal of Respiratory and Critical Care Medicine 167(10): 1416-1426
Schmidt-Supprian, M.; Murphy, C.; While, B.; Lawler, M.; Kapurniotu, A.; Voelter, W.; Smith, O.; Bernhagen, J. 2000: Activated protein C inhibits tumor necrosis factor and macrophage migration inhibitory factor production in monocytes. European Cytokine Network 11(3): 407-413
Isobe, H.; Okajima, K.; Uchiba, M.; Mizutani, A.; Harada, N.; Nagasaki, A.; Okabe, K. 2001: Activated protein C prevents endotoxin-induced hypotension in rats by inhibiting excessive production of nitric oxide. Circulation 104(10): 1171-1175
Yoshikawa, A.; Kaido, T.; Seto, S.; Katsuura, Y.; Imamura, M. 2000: Activated protein C prevents multiple organ injury following extensive hepatectomy in cirrhotic rats. Journal of Hepatology 33(6): 953-960
Mizutani, A.; Okajima, K.; Uchiba, M.; Noguchi, T. 2000: Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation. Blood 95(12): 3781-3787
Lindqvist, P.G.; Svensson, P.J.; Marsaál, K.; Grennert, L.; Luterkort, M.; Dahlbäck, B. 1999: Activated protein C resistance (FV:Q506) and pregnancy. Thrombosis and Haemostasis 81(4): 532-537
Leroy-Matheron, C.; Duvoux, C.; Van Nhieu, J.Tran.; Leroy, K.; Cherqui, D.; Gouault-Heilmann, Mèle. 2003: Activated protein C resistance acquired through liver transplantation and associated with recurrent venous thrombosis. Journal of Hepatology 38(6): 866-869
Zunker, P.; Hohenstein, C.; Plendl, H.J.; Zeller, J.A.; Caso, V.; Georgiadis, D.; Allardt, A.; Deuschl, G. 2001: Activated protein C resistance and acute ischaemic stroke: Relation to stroke causation and age. Journal of Neurology 248(8): 701-704
Maréchal, V.; De Maistre, E.; Barbaud, A.; Albuisson, E.; Lecompte, T.; Gobert, B.; Bene, M.; Faure, G.; Schmutz, J. 2000: Activated protein C resistance and cardiolipin antibodies in leg ulcers. Annales de Dermatologie et de Venereologie 127(6-7): 585-589
Rodeghiero, F.; Tosetto, A. 1999: Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism. Annals of Internal Medicine 130(8): 643-650
Younis, J.S.; Brenner, B.; Ohel, G.; Tal, J.; Lanir, N.; Ben-Ami, M. 2000: Activated protein C resistance and factor V Leiden mutation can be associated with first-as well as second-trimester recurrent pregnancy loss. American Journal of Reproductive Immunology 43(1): 31-35
Kayiran, S.M.; Ozbek, N.; Caner, H.; Tokel, K.; Mercan, S.; Alehan, F. 2001: Activated protein C resistance and false type 2 protein C deficiency detected after multiple shunt failures in a patient with hydrocephalus. Journal of Child Neurology 16(11): 862-863
Strobl, F.J.; Hoffman, S.; Huber, S.; Williams, E.C.; Voelkerding, K.V. 1998: Activated protein C resistance assay performance: improvement by sample dilution with factor V-deficient plasma. Archives of Pathology and Laboratory Medicine 122(5): 430-433
Katz, V.L.; DiTomasso, J.; Farmer, R.; Carpenter, M. 2002: Activated protein C resistance associated with maternal floor infarction treated with low-molecular-weight heparin. American Journal of Perinatology 19(5): 273-277
Tans, G.; van Hylckama Vlieg, A.; Thomassen, M.Christella.L.G.D.; Curvers, J.; Bertina, R.M.; Rosing, J.; Rosendaal, F.R. 2003: Activated protein C resistance determined with a thrombin generation-based test predicts for venous thrombosis in men and women. British Journal of Haematology 122(3): 465-470
Cetin, M.; Güçer, S.; Serin, I.S.; Eser, B.; Tayyar, M.; Unal, A. 2001: Activated protein C resistance in Turkish women with severe preeclampsia. Gynecologic and Obstetric Investigation 52(3): 168-172
Zangari, M.; Saghafifar, F.; Anaissie, E.; Badros, A.; Desikan, R.; Fassas, A.; Mehta, P.; Morris, C.; Toor, A.; Whitfield, D.; Siegel, E.; Barlogie, B.; Fink, L.; Tricot, G. 2002: Activated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complications. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 13(3): 187-192
Chaturvedi, S.; Joshi, N.; Dzieczkowski, J. 1999: Activated protein C resistance in young African American patients with ischemic stroke. Journal of the Neurological Sciences 163(2): 137-139
Rulon, J.J.; Cho, C.G.; Guerra, L.L.; Bux, R.C.; Gulley, M.L. 1999: Activated protein C resistance is uncommon in sudden death due to pulmonary embolism. Journal of Forensic Sciences 44(6): 1111-1113
Horstkamp, B.S.; Kiess, H.; Krämer, J.; Riess, H.; Henrich, W.; Dudenhausen, J.W. 1999: Activated protein C resistance shows an association with pregnancy-induced hypertension. Human Reproduction 14(12): 3112-3115
Van Cott, E.M.; Soderberg, B.L.; Laposata, M. 2002: Activated protein C resistance, the factor V Leiden mutation, and a laboratory testing algorithm. Archives of Pathology and Laboratory Medicine 126(5): 577-582
Lim, L.C.; Tan, H.H.; Lee, L.H.; Tien, S.L.; Abdul Ghafar, A. 1999: Activated protein C resistance: a study among 60 thromboembolic patients in the Singapore population. Annals of the Academy of Medicine Singapore 28(2): 252-255
Klingler, K.R.; Junold, T.; Wielckens, K. 1999: Activated protein C resistance: automated detection of the factor V Leiden mutation by mismatch hybridization. Clinical Chemistry 45(11): 1925-1931
Taube, J.; McWilliam, N.; Luddington, R.; Byrne, C.D.; Baglin, T. 1999: Activated protein C resistance: effect of platelet activation, platelet-derived microparticles, and atherogenic lipoproteins. Blood 93(11): 3792-3797
Shua, F.; Kobayashia, H.; Fukudomeb, K.; Tsuneyoshib, N.; Kimotob, M.; Teraoa, T. 2000: Activated protein C suppresses tissue factor expression on U937 cells in the endothelial protein C receptor-dependent manner. FEBS Letters 477(3): 208-212
Heeb, M.J.; Griffin, J.H. 2002: Activated protein C-dependent and -independent anticoagulant activities of protein S have different structural requirements. Blood Cells Molecules and Diseases 29(2): 190-199
Strandberg, K.; Kjellberg, M.; Erb, E.M.; Persson, U.; Mosher, D.F.; Villoutreix, B.O.; Stenflo, J. 2000: Activated protein C-protein C inhibitor complex formation: Characterization of a neoepitope provides evidence for extensive insertion of the reactive center loop. Biochemistry 39(51): 15713-15720
Miyasaka, S.; Ichiba, T.; Kuroda, H.; Ohgi, S. 1999: Activated protein kinase C attenuates Ca2+ overloading and reoxygenation hypercontracture in isolated rat cardiomyocytes following chemical hypoxia. Yonago Acta Medica 42(1): 31-39
Rybin, V.O.; Xu, X.; Steinberg, S.F. 1999: Activated protein kinase C isoforms target to cardiomyocyte caveolae : stimulation of local protein phosphorylation. Circulation Research 84(9): 980-988
Masamune, A.; Sakai, Y.; Kikuta, K.; Satoh, M.; Satoh, A.; Shimosegawa, T. 2002: Activated rat pancreatic stellate cells express intercellular adhesion molecule-1 (ICAM-1) in vitro. Pancreas 25(1): 78-85
Liebman, H.A.; Chediak, J.; Fink, K.I.; Galvez, A.G.; Shah, P.C.; Sham, R.L. 2000: Activated recombinant human coagulation factor VII (rFVIIa) therapy for abdominal bleeding in patients with inhibitory antibodies to factor VIII. American Journal of Hematology 63(3): 109-113
McLoon, L.K.; Wirtschafter, J. 2003: Activated satellite cells in extraocular muscles of normal adult monkeys and humans. IOVS Investigative Ophthalmology and Visual Science 44(5): 1927-1932
Scholz, A.; Heinze, S.; Detjen, K.M.; Peters, M.; Welzel, M.; Hauff, P.; Schirner, M.; Wiedenmann, B.; Rosewicz, S. 2003: Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancer. Gastroenterology 125(3): 891-905
Satoh, H.; Iwamoto, Y.; Mino, T.; Matsuo, T. 1998: Activated sludge as a possible source of biodegradable plastic. Water Science and Technology 38(2): 103-109
Vazquez-Rodriguez, G.; Goma, G.; Rols, J.L. 2003: Activated sludge as inoculum for ready biodegradability testing: effect of source. Environmental Technology 24(8): 979-987
Piirtola, L.; Hultman, B.; Andersson, C.; Lundeberg, Y. 1999: Activated sludge ballasting in batch tests. Water Research 33(8): 1799-1804
Piirtola, L.; Hultman, B.; Lowen, M. 1999: Activated sludge ballasting in pilot plant operation. Water Research 33(13): 3026-3032
Gebara, F. 1999: Activated sludge biofilm wastewater treatment system. Water Research 33(1): 230-238
Görner, T.; de Donato, P.; Ameil, M.H.él.èn.; Montarges-Pelletier, E.; Lartiges, B.S. 2003: Activated sludge exopolymers: separation and identification using size exclusion chromatography and infrared micro-spectroscopy. Water Research 37(10): 2388-2393
Biggs, C.A.; Ford, A.M.; Lant, P.A. 2001: Activated sludge flocculation: direct determination of the effect of calcium ions. Water Science and Technology: a Journal of the International Association on Water Pollution Research 43(11): 75-82
An, M.; Lo, K.V. 2001: Activated sludge immobilization using the PVA-alginate-borate method. Journal of Environmental Science and Health. Part A Toxic/Hazardous Substances and Environmental Engineering 36(1): 101-115
Krist Gernaey, A.; Petersen, B.; Ottoy, J.P.; Vanrolleghem, P. 2001: Activated sludge monitoring with combined respirometric-titrimetric measurements. Water Research 35(5): 1280-1294
Wanner, J.; Ruzickova, I.; Krhutkova, O.; Pribyl, M. 2000: Activated sludge population dynamics and wastewater treatment plant design and operation. Water Science and Technology 41(9): 217-225
Cheng, C.Y.; Ribarova, I. 1999: Activated sludge system modelling and simulations for improving the effluent water quality. Water Science and Technology 39(8): 93-98
Yakirevich, E.; Lefel, O.; Sova, Y.; Stein, A.; Cohen, O.; Izhak, O.B.; Resnick, M.B. 2002: Activated status of tumour-infiltrating lymphocytes and apoptosis in testicular seminoma. Journal of Pathology 196(1): 67-75
Oide, H.; Tateyama, M.; Wang, X.E.; Hirose, M.; Itatsu, T.; Watanabe, S.; Ochi, R.; Sato, N. 1999: Activated stellate (Ito) cells possess voltage-activated calcium current. Biochimica et Biophysica Acta 1418(1): 158-164
Taimr, P.; Higuchi, H.; Kocova, E.; Rippe, R.A.; Friedman, S.; Gores, G.J. 2003: Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis. Hepatology 37(1): 87-95
Koeplinger, K.A.; Zhao, Z.; Peterson, T.; Leone, J.W.; Schwende, F.S.; Heinrikson, R.L.; Tomasselli, A.G. 1999: Activated sulfonamides are cleaved by glutathione-S-transferases. Drug Metabolism and Disposition: the Biological Fate of Chemicals 27(9): 986-991
Wu, C.; Dong, N.; da Cunha, V.; Martin-McNulty, B.; Tran, K.; Nagashima, M.; Wu, Q.; Morser, J.; Wang, Y.-X. 2003: Activated thrombin-activatable fibrinolysis inhibitor attenuates spontaneous fibrinolysis of batroxobin-induced fibrin deposition in rat lungs. Thrombosis and Haemostasis 90(3): 414-421
Benz, C.; Utermöhlen, O.; Wulf, A.; Villmow, B.; Dries, V.; Goeser, T.; Koszinowski, U.; Busch, D.H. 2002: Activated virus-specific T cells are early indicators of anti-CMV immune reactions in liver transplant patients. Gastroenterology 122(5): 1201-1215
Lécart, S.; Lecointe, N.; Subramaniam, A.; Alkan, S.; Ni, D.; Chen, R.; Boulay, V.; Pène, J.ér.ôm.; Kuroiwa, K.; Tominaga, S.-i.; Yssel, H. 2002: Activated, but not resting human Th2 cells, in contrast to Th1 and T regulatory cells, produce soluble ST2 and express low levels of ST2L at the cell surface. European Journal of Immunology 32(10): 2979-2987
Rabinovich, B.A.; Li, J.; Shannon, J.; Hurren, R.; Chalupny, J.; Cosman, D.; Miller, R.G. 2003: Activated, but not resting, T cells can be recognized and killed by syngeneic NK cells. Journal of Immunology 170(7): 3572-3576
Fee, D.; Crumbaugh, A.; Jacques, T.; Herdrich, B.; Sewell, D.; Auerbach, D.; Piaskowski, S.; Hart, M.N.; Sandor, M.; Fabry, Z. 2003: Activated/effector CD4+ T cells exacerbate acute damage in the central nervous system following traumatic injury. Journal of Neuroimmunology 136(1-2): 54-66
Belyakov, I.M.; Wang, J.; Koka, R.; Ahlers, J.D.; Snyder, J.T.; Tse, R.; Cox, J.; Gibbs, J.S.; Margulies, D.H.; Berzofsky, J.A. 2001: Activating CTL precursors to reveal CTL function without skewing the repertoire by in vitro expansion. European Journal of Immunology 31(12): 3557-3566
Okamoto, S.; Hisaoka, M.; Ushijima, M.; Nakahara, S.; Toyoshima, S.; Hashimoto, H. 2000: Activating Gs(alpha) mutation in intramuscular myxomas with and without fibrous dysplasia of bone. Virchows Archiv: An International Journal of Pathology 437(2): 133-137
Ortaldo, J.R.; Winkler-Pickett, R.; Wiegand, G. 2000: Activating Ly-49D NK receptors: expression and function in relation to ontogeny and Ly-49 inhibitor receptors. Journal of Leukocyte Biology 68(5): 748-756
Nakamura, M.C.; Hayashi, S.; Niemi, E.C.; Ryan, J.C.; Seaman, W.E. 2000: Activating Ly-49D and inhibitory Ly-49A natural killer cell receptors demonstrate distinct requirements for interaction with H2-D(d). Journal of Experimental Medicine 192(3): 447-454
Bezieau, Séphane.; Avet-Loiseau, Hé.; Moisan, J-Paul.; Bataille, Régis. 2002: Activating Ras mutations in patients with plasma-cell disorders: a reappraisal. Blood 100(3): 1101-2; author reply 1103
Huhtaniemi, I. 2000: Activating and inactivating hormone receptor mutations. Hormone Research 53(Suppl): 9-16
Themmen, A.P.N.; Martens, J.W.M.; Brunner, H.G. 1998: Activating and inactivating mutations in LH receptors. Molecular and Cellular Endocrinology 145(1-2): 137-142
Aldred, M.A.; Trembath, R.C. 2000: Activating and inactivating mutations in the human GNAS1 gene. Human Mutation 16(3): 183-189
Dhillon, S.; Das, A.; Saxena, R., K. 1999: Activating and inhibitory receptors on natural killer lymphocytes. Proceedings of the National Academy of Sciences India, Section B, Biological Sciences 69(3-4): 229-243
Ott, V.L.; Cambier, J.C. 2000: Activating and inhibitory signaling in mast cells: new opportunities for therapeutic intervention?. Journal of Allergy and Clinical Immunology 106(3): 429-440
Jahns, R.; Boivin, V.; Siegmund, C.; Boege, F.; Lohse, M.J.; Inselmann, G. 1999: Activating beta-1-adrenoceptor antibodies are not associated with cardiomyopathies secondary to valvular or hypertensive heart disease. Journal of the American College of Cardiology 34(5): 1545-1551
Qu-Qinghui; Kang-Jun; Wu-Jie; Et-Al 2002: Activating blood and eliminating stasis effects of Pingxiao capsules. Xi'an Yike Daxue Xuebao 23(3): 308-310
Tian, Q.; Frierson, H.F.; Krystal, G.W.; Moskaluk, C.A. 1999: Activating c-kit gene mutations in human germ cell tumors. American Journal of Pathology 154(6): 1643-1647
Slabbekoorn, D.; van Goozen, S.H.; Megens, J.; Gooren, L.J.; Cohen-Kettenis, P.T. 1999: Activating effects of cross-sex hormones on cognitive functioning: A study of short-term and long-term hormone effects in transsexuals. Psychoneuroendocrinology 24(4): 423-447
Yamaguchi, M.; Takemori, S. 2001: Activating efficiency of Ca2+ and cross-bridges as measured by phosphate analog release. Biophysical Journal 80(1): 371-378
Trobonjaca, Z.; Kröger, A.; Stober, D.; Leithäuser, F.; Möller, P.; Hauser, H.ör.; Schirmbeck, R.; Reimann, J.ör. 2002: Activating immunity in the liver. II. IFN-beta attenuates NK cell-dependent liver injury triggered by liver NKT cell activation. Journal of Immunology 168(8): 3763-3770
Nakajima, H.; Cella, M.; Langen, H.; Friedlein, A.; Colonna, M. 1999: Activating interactions in human NK cell recognition: the role of 2B4-CD48. European Journal of Immunology 29(5): 1676-1683
Tyler, L.K.; Moss, H.E.; Galpin, A.; Voice, J.K.te 2002: Activating meaning in time: The role of imageability and form-class. Language and Cognitive Processes 17(5): 471-502
Yamamoto, Y.; Kiyoi, H.; Nakano, Y.; Suzuki, R.; Kodera, Y.; Miyawaki, S.; Asou, N.; Kuriyama, K.; Yagasaki, F.; Shimazaki, C.; Akiyama, H.; Saito, K.; Nishimura, M.; Motoji, T.; Shinagawa, K.; Takeshita, A.; Saito, H.; Ueda, R.; Ohno, R.; Naoe, T. 2001: Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies. Blood 97(8): 2434-2439
Zimmermann, G.; Zhou, D.; Taussig, R. 1999: Activating mutation of adenylyl cyclase reverses its inhibition by G proteins. Molecular Pharmacology 56(5): 895-901
Dank, G.; Chien, M.B.; London, C.A. 2002: Activating mutations in the catalytic or juxtamembrane domain of c-kit in splenic mast cell tumors of cats. American Journal of Veterinary Research 63(8): 1129-1133
Meshinchi, S.; Stirewalt, D.L.; Alonzo, T.A.; Zhang, Q.; Sweetser, D.A.; Woods, W.G.; Bernstein, I.D.; Arceci, R.J.; Radich, J.P. 2003: Activating mutations of RTK/ras signal transduction pathway in pediatric acute myeloid leukemia. Blood 102(4): 1474-1479
Rodien, P.; Ho, S-C.; Vlaeminck, V.; Vassart, G.; Costagliola, S. 2003: Activating mutations of TSH receptor. Annales D'endocrinologie 64(1): 12-16
Beck Peccoz, P.; Persani, L.; Romoli, R.; Asteria, C.; Borgato, S. 1998: Activating mutations of gonadotrophin receptors. Archives de Pediatrie 5(Suppl 4): 380S-384S
Polak, M. 1998: Activating mutations of the TSH receptor: A synthesis highlighting some pediatric aspects. Archives de Pediatrie 5(Suppl 4): 375S-379S
Lienhardt, A.; Bai, M.; Lagarde, J.P.; Rigaud, M.; Zhang, Z.; Jiang, Y.; Kottler, M.L.; Brown, E.M.; Garabédian, M. 2001: Activating mutations of the calcium-sensing receptor: management of hypocalcemia. Journal of Clinical Endocrinology and Metabolism 86(11): 5313-5323
David, L. 1998: Activating mutations of the receptors of parathyroid hormone and parathyroid hormone related peptide. Archives de Pediatrie 5(Suppl 4): 385S-389S
Torshin, I. 1999: Activating oligomerization as intermediate level of signal transduction: analysis of protein-protein contacts and active sites in several glycolytic enzymes. Frontiers in Bioscience: a Journal and Virtual Library 4: D557-D570
Zackova, Méta.; Skobisová, E.; Urbánková, E.; Jezek, P. 2003: Activating omega-6 polyunsaturated fatty acids and inhibitory purine nucleotides are high affinity ligands for novel mitochondrial uncoupling proteins UCP2 and UCP3. Journal of Biological Chemistry 278(23): 20761-20769
Kimmelman, J.; Kaldis, P.; Hengartner, C.J.; Laff, G.M.; Koh, S.S.; Young, R.A.; Solomon, M.J. 1999: Activating phosphorylation of the Kin28p subunit of yeast TFIIH by Cak1p. Molecular and Cellular Biology 19(7): 4774-4787
Ross, K.E.; Kaldis, P.; Solomon, M.J. 2000: Activating phosphorylation of the Saccharomyces cerevisiae cyclin-dependent kinase, cdc28p, precedes cyclin binding. Molecular Biology of the Cell 11(5): 1597-1609
Vax, V.V.; Bibi, R.; Diaz-Cano, S.; Gueorguiev, M.; Kola, B.; Borboli, N.; Bressac-de Paillerets, B.; Walker, G.J.; Dedov, I.I.; Grossman, A.B.; Korbonits, M. 2003: Activating point mutations in cyclin-dependent kinase 4 are not seen in sporadic pituitary adenomas, insulinomas or Leydig cell tumours. Journal of Endocrinology 178(2): 301-310
Lee, S.K.; Na, S.Y.; Jung, S.Y.; Choi, J.E.; Jhun, B.H.; Cheong, J.; Meltzer, P.S.; Lee, Y.C.; Lee, J.W. 2000: Activating protein-1, nuclear factor-kappaB, and serum response factor as novel target molecules of the cancer-amplified transcription coactivator ASC-2. Molecular Endocrinology 14(6): 915-925
Waring, M.D.; Ponton, C.W.; Don, M. 1999: Activating separate ascending auditory pathways produces different human thalamic/cortical responses. Hearing Research 130(1-2): 219-229
Lee, Y.Soo.; Kim, H-Jin.; Lee, H.Ju.; Lee, J.Woon.; Chun, S-Young.; Ko, S-Kun.; Lee, K. 2002: Activating signal cointegrator 1 is highly expressed in murine testicular Leydig cells and enhances the ligand-dependent transactivation of androgen receptor. Biology of Reproduction 67(5): 1580-1587
Kim, H.J.; Yi, J.Y.; Sung, H.S.; Moore, D.D.; Jhun, B.H.; Lee, Y.C.; Lee, J.W. 1999: Activating signal cointegrator 1, a novel transcription coactivator of nuclear receptors, and its cytosolic localization under conditions of serum deprivation. Molecular and Cellular Biology 19(9): 6323-6332
Kim, S.-W.; Park, K.; Kwak, E.; Choi, E.; Lee, S.; Ham, J.; Kang, H.; Kim, J.M.; Hwang, S.Y.; Kong, Y.-Y.; Lee, K.; Lee, J.W. 2003: Activating signal cointegrator 2 required for liver lipid metabolism mediated by liver X receptors in mice. Molecular and Cellular Biology 23(10): 3583-3592
Su, T.T.; Walker, J.; Stumpff, J. 2000: Activating the DNA damage checkpoint in a developmental context. Current Biology: Cb 10(3): 119-126
Tonacchera, M.; Agretti, P.; Chiovato, L.; Rosellini, V.; Ceccarini, G.; Perri, A.; Viacava, P.; Naccarato, A.G.; Miccoli, P.; Pinchera, A.; Vitti, P. 2000: Activating thyrotropin receptor mutations are present in nonadenomatous hyperfunctioning nodules of toxic or autonomous multinodular goiter. Journal of Clinical Endocrinology and Metabolism 85(6): 2270-2274
Beier, F.; Taylor, A.C.; LuValle, P. 2000: Activating transcription factor 2 is necessary for maximal activity and serum induction of the cyclin A promoter in chondrocytes. Journal of Biological Chemistry 275(17): 12948-12953
Tsujino, H.; Kondo, E.; Fukuoka, T.; Dai, Y.; Tokunaga, A.; Miki, K.; Yonenobu, K.; Ochi, T.; Noguchi, K. 2000: Activating transcription factor 3 (ATF3) induction by axotomy in sensory and motoneurons: a novel neuronal marker of nerve injury. Molecular and Cellular Neurosciences 15(2): 170-182
Allan, A.L.; Albanese, C.; Pestell, R.G.; LaMarre, J. 2001: Activating transcription factor 3 induces DNA synthesis and expression of cyclin D1 in hepatocytes. Journal of Biological Chemistry 276(29): 27272-27280
Ban, N.; Yamada, Y.; Someya, Y.; Ihara, Y.; Adachi, T.; Kubota, A.; Watanabe, R.; Kuroe, A.; Inada, A.; Miyawaki, K.; Sunaga, Y.; Shen, Z.P.; Iwakura, T.; Tsukiyama, K.; Toyokuni, S.; Tsuda, K.; Seino, Y. 2000: Activating transcription factor-2 is a positive regulator in CaM kinase IV-induced human insulin gene expression. Diabetes 49(7): 1142-1148
Lee, M.Young.; Jung, C-Hun.; Lee, K.; Choi, Y.Hyun.; Hong, S.; Cheong, J. 2002: Activating transcription factor-2 mediates transcriptional regulation of gluconeogenic gene PEPCK by retinoic acid. Diabetes 51(12): 3400-3407
Thor, A.D.; Liu, S.; Edgerton, S.; Moore, D.; Kasowitz, K.M.; Benz, C.C.; Stern, D.F.; DiGiovanna, M.P. 2000: Activation (tyrosine phosphorylation) of ErbB-2 (HER-2/neu): a study of incidence and correlation with outcome in breast cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 18(18): 3230-3239
Zhang, J.; Xiao, Y.; Abdrakhmanova, G.; Wang, W.; Cleemann, L.; Kellar, K.J.; Morad, M. 1999: Activation and Ca2+ permeation of stably transfected alpha3/beta4 neuronal nicotinic acetylcholine receptor. Molecular Pharmacology 55(6): 970-981
Leonard, B.J.; Clarke, B.J.; Sridhara, S.; Kelley, R.; Ofosu, F.A.; Blajchman, M.A. 2000: Activation and active site occupation alter conformation in the region of the first epidermal growth factor-like domain of human factor VIi. Journal of Biological Chemistry 275(45): 34894-34900
Bálint E, E.; Vousden, K.H. 2001: Activation and activities of the p53 tumour suppressor protein. British Journal of Cancer 85(12): 1813-1823
Bode, A.P.; Read, M.S.; Reddick, R.L. 1999: Activation and adherence of lyophilized human platelets on canine vessel strips in the Baumgartner perfusion chamber. Journal of Laboratory and Clinical Medicine 133(2): 200-211
Benschop, R.J.; Aviszus, K.; Zhang, X.; Manser, T.; Cambier, J.C.; Wysocki, L.J. 2001: Activation and anergy in bone marrow B cells of a novel immunoglobulin transgenic mouse that is both hapten specific and autoreactive. Immunity 14(1): 33-43
Kizaki, T.; Suzuki, K.; Hitomi, Y.; Iwabuchi, K.; Onoé, K.; Ishida, H.; Izawa, T.; Ji, L.L.; Ohno, H.; Kizkai, T. 2001: Activation and apoptosis of murine peritoneal macrophages by acute cold stress. Biochemical and Biophysical Research Communications 283(3): 700-706
Kline, J.B.; Moore, D.J.; Clevenger, C.V. 2001: Activation and association of the Tec tyrosine kinase with the human prolactin receptor: mapping of a Tec/Vav1-receptor binding site. Molecular Endocrinology 15(5): 832-841
Zhang, Q.; Zhang, G. 2002: Activation and autophosphorylation of apoptosis signal-regulating kinase 1 (ASK1) following cerebral ischemia in rat hippocampus. Neuroscience Letters 329(2): 232-236
Liu, J.; Li, H.; Burstein, S.H.; Zurier, R.B.; Chen, J.Don. 2003: Activation and binding of peroxisome proliferator-activated receptor gamma by synthetic cannabinoid ajulemic acid. Molecular Pharmacology 63(5): 983-992
Magazanik, L.G.; Dorofeeva, N.A.; Lavrent'eva, V.V.; Potapjeva, N.N.; Gmiro, V.E.; Samoilova, M.V.; Tikhonov, D.B.; Frolova, E.V. 2002: Activation and blockade of nicotinic cholinoreceptors by dicationic adamantane derivatives. Biologicheskie Membrany 19(1): 32-41
Los, M.; Mozoluk, M.; Ferrari, D.; Stepczynska, A.; Stroh, C.; Renz, A.; Herceg, Z.; Wang, Z.-Q.; Schulze-Osthoff, K. 2002: Activation and caspase-mediated inhibition of PARP: a molecular switch between fibroblast necrosis and apoptosis in death receptor signaling. Molecular Biology of the Cell 13(3): 978-988
Orendi, J.M.; Bloem, A.C.; Borleffs, J.C.; Wijnholds, F.J.; de Vos, N.M.; Nottet, H.S.; Visser, M.R.; Snippe, H.; Verhoef, J.; Boucher, C.A. 1998: Activation and cell cycle antigens in CD4+ and CD8+ T cells correlate with plasma human immunodeficiency virus (HIV-1) RNA level in HIV-1 infection. Journal of Infectious Diseases 178(5): 1279-1287
Bergendorff, O.; Hansson, C. 2000: Activation and cross-reactivity pattern of a new allergen in adhesive plaster. Contact Dermatitis 42(1): 11-17
Platonov, A.E.; Vershinina, I.V.; Gracheva, A.M. 1999: Activation and damage of human granulocytes by meningococcal lipopolysaccharide and autologous complement. Immunologiya 1999(2): 29-35
Schouppe, C.; Vaillier, J.; Venard, R.; Rigoulet, M.; Velours, J.; Haraux, F. 1999: Activation and deactivation of F0F1-ATPase in yeast mitochondria. Journal of Bioenergetics and Biomembranes 31(2): 105-117
Yamamoto, N.; Hegde, A.N.; Chain, D.G.; Schwartz, J.H. 1999: Activation and degradation of the transcription factor C/EBP during long-term facilitation in Aplysia. Journal of Neurochemistry 73(6): 2415-2423
Esteban, S.; Lladó, J.; Sastre-Coll, A.; García-Sevilla, J.A. 1999: Activation and desensitization by cyclic antidepressant drugs of alpha2-autoreceptors, alpha2-heteroreceptors and 5-HT1A-autoreceptors regulating monamine synthesis in the rat brain in vivo. Naunyn-Schmiedeberg's Archives of Pharmacology 360(2): 135-143
Paternain, A.V.; Rodríguez-Moreno, A.; Villarroel, A.; Lerma, J. 1998: Activation and desensitization properties of native and recombinant kainate receptors. Neuropharmacology 37(10-11): 1249-1259
Watanabe, N.; Ikuta, K.; Nisitani, S.; Chiba, T.; Honjo, T. 2002: Activation and differentiation of autoreactive B-1 cells by interleukin 10 induce autoimmune hemolytic anemia in Fas-deficient antierythrocyte immunoglobulin transgenic mice. Journal of Experimental Medicine 196(1): 141-146
Han, J.-Q.; Barton, D.J. 2002: Activation and evasion of the antiviral 2'-5' oligoadenylate synthetase/ribonuclease L pathway by hepatitis C virus mRNA. Rna 8(4): 512-525
Mohi, M.G.; Arai, K.i.; Watanabe, S. 1998: Activation and functional analysis of Janus kinase 2 in BA/F3 cells using the coumermycin/gyrase B system. Molecular Biology of the Cell 9(12): 3299-3308
Jacobsen, L.; Madsen, P.; Jacobsen, C.; Nielsen, M.S.; Gliemann, J.; Petersen, C.M. 2001: Activation and functional characterization of the mosaic receptor SorLA/LR11. Journal of Biological Chemistry 276(25): 22788-22796
Flesch, M.; Höper, A.; Dell'Italia, L.; Evans, K.; Bond, R.; Peshock, R.; Diwan, A.; Brinsa, T.A.; Wei, C-Chang.; Sivasubramanian, N.; Spinale, F.G.; Mann, D.L. 2003: Activation and functional significance of the renin-angiotensin system in mice with cardiac restricted overexpression of tumor necrosis factor. Circulation 108(5): 598-604
Bolognese, F.; Di Lecce, C.; Galli, E.; Barbieri, P. 1999: Activation and inactivation of Pseudomonas stutzeri methylbenzene catabolism pathways mediated by a transposable element. Applied and Environmental Microbiology 65(5): 1876-1882
Kamkin, A.; Kiseleva, I.; Isenberg, G. 2003: Activation and inactivation of a non-selective cation conductance by local mechanical deformation of acutely isolated cardiac fibroblasts. Cardiovascular Research 57(3): 793-803
Müller, F.U.; Bokník, P.; Knapp, J.; Linck, B.; Lüss, H.; Neumann, J.; Schmitz, W. 2001: Activation and inactivation of cAMP-response element-mediated gene transcription in cardiac myocytes. Cardiovascular Research 52(1): 95-102
Hwang, D.; Chanmugam, P.; Boudreau, M.; Sohn, K.H.; Stone, K.; Pryor, W.A. 1999: Activation and inactivation of cyclo-oxygenase in rat alveolar macrophages by aqueous cigarette tar extracts. Free Radical Biology and Medicine 27(5-6): 673-682
Bett, G.C.; Sachs, F. 2000: Activation and inactivation of mechanosensitive currents in the chick heart. Journal of Membrane Biology 173(3): 237-254
Basso, M.A.; Krauzlis, R.J.; Wurtz, R.H. 2000: Activation and inactivation of rostral superior colliculus neurons during smooth-pursuit eye movements in monkeys. Journal of Neurophysiology 84(2): 892-908
Kaur, N.; Wohlhueter, A.L.; Halvorsen, S.W. 2002: Activation and inactivation of signal transducers and activators of transcription by ciliary neurotrophic factor in neuroblastoma cells. Cellular Signalling 14(5): 419-429
Cardin, V.; Peña-Segura, C.; Pasantes-Morales, H. 1999: Activation and inactivation of taurine efflux in hyposmotic and isosmotic swelling in cortical astrocytes: Role of ionic strength and cell volume decrease. Journal of Neuroscience Research 56(6): 659-667
Bendahhou, S.; Cummins, T.R.; Tawil, R.; Waxman, S.G.; Ptácek, L.J. 1999: Activation and inactivation of the voltage-gated sodium channel: role of segment S5 revealed by a novel hyperkalaemic periodic paralysis mutation. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 19(12): 4762-4771
Kovalovsky, D.án.; Refojo, D.án.; Liberman, A.C.; Hochbaum, D.; Pereda, M.P.; Coso, O.A.; Stalla, G.ün.K.; Holsboer, F.; Arzt, E. 2002: Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways. Molecular Endocrinology 16(7): 1638-1651
Breitweg-Lehmann, E.; Czupalla, C.; Storm, R.üd.; Kudlacek, O.; Schunack, W.; Freissmuth, M.; Nürnberg, B. 2002: Activation and inhibition of G proteins by lipoamines. Molecular Pharmacology 61(3): 628-636
Bouchard, M.J.; Puro, R.J.; Wang, L.; Schneider, R.J. 2003: Activation and inhibition of cellular calcium and tyrosine kinase signaling pathways identify targets of the HBx protein involved in hepatitis B virus replication. Journal of Virology 77(14): 7713-7719
Maingonnat, C.; Victor, R.; Bertrand, P.; Courel, M.N.; Maunoury, R.; Delpech, B. 1999: Activation and inhibition of human cancer cell hyaluronidase by proteins. Analytical Biochemistry 268(1): 30-34
Frauwirth, K.A.; Thompson, C.B. 2002: Activation and inhibition of lymphocytes by costimulation. Journal of Clinical Investigation 109(3): 295-299
Levi-Schaffer, F.; Slovik, D.; Armetti, L.; Pickholtz, D.; Touitou, E. 2000: Activation and inhibition of mast cells degranulation affect their morphometric parameters. Life Sciences 66(21): PL283-PL290
Uteshev, V.V.; Meyer, E.M.; Papke, R.L. 2002: Activation and inhibition of native neuronal alpha-bungarotoxin-sensitive nicotinic ACh receptors. Brain Research 948(1-2): 33-46
Suko, J.; Drobny, H.; Hellmann, G. 1999: Activation and inhibition of purified skeletal muscle calcium release channel by NO donors in single channel current recordings. Biochimica et Biophysica Acta 1451(2-3): 271-287
Dulhunty, A.F.; Laver, D.R.; Gallant, E.M.; Casarotto, M.G.; Pace, S.M.; Curtis, S. 1999: Activation and inhibition of skeletal RyR channels by a part of the skeletal DHPR II-IIi loop: effects of DHPR Ser687 and FKBP12. Biophysical Journal 77(1): 189-203
Koshino, H. 2001: Activation and inhibition of stimulus features in conjunction search. Psychonomic Bulletin and Review 8(2): 294-300
Saakyan, I.R.; Saakyan, S.G.; Kondrashova, M.N. 2001: Activation and inhibition of succinate-dependent Ca2+ transport in liver mitochondria during adaptation. Biochemistry. Biokhimiia 66(7): 795-802
Briggs, C.A.; McKenna, D.G. 1998: Activation and inhibition of the human alpha7 nicotinic acetylcholine receptor by agonists. Neuropharmacology 37(9): 1095-1102
Mossman, K.L. 2002: Activation and inhibition of virus and interferon: the herpesvirus story. Viral Immunology 15(1): 3-15
Siegelman, M.H.; DeGrendele, H.C.; Estess, P. 1999: Activation and interaction of CD44 and hyaluronan in immunological systems. Journal of Leukocyte Biology 66(2): 315-321
McConalogue, K.; Grady, E.F.; Minnis, J.; Balestra, B.; Tonini, M.; Brecha, N.C.; Bunnett, N.W.; Sternini, C. 1999: Activation and internalization of the mu-opioid receptor by the newly discovered endogenous agonists, endomorphin-1 and endomorphin-2. Neuroscience 90(3): 1051-1059
Hart, L.A.; Krishnan, V.L.; Adcock, I.M.; Barnes, P.J.; Chung, K.F. 1998: Activation and localization of transcription factor, nuclear factor-kappaB, in asthma. American Journal of Respiratory and Critical Care Medicine 158(5 Part 1): 1585-1592
Horiike, N.; Md Fazle Akbar, S.; Ninomiya, T.; Abe, M.; Michitaka, K.; Onji, M. 2002: Activation and maturation of antigen-presenting dendritic cells during vaccine therapy in patients with chronic hepatitis due to hepatitis B virus. Hepatology Research: the Official Journal of the Japan Society of Hepatology 23(1): 38-47
Caruso, M.; Maitan, M.A.; Bifulco, G.; Miele, C.; Vigliotta, G.; Oriente, F.; Formisano, P.; Beguinot, F. 2001: Activation and mitochondrial translocation of protein kinase Cdelta are necessary for insulin stimulation of pyruvate dehydrogenase complex activity in muscle and liver cells. Journal of Biological Chemistry 276(48): 45088-45097
Elsner, J.; Kapp, A. 2000: Activation and modulation of eosinophils by chemokines. Allergologie 23(2): 59-72
Farshori, P.Q.; Shah, B.H.; Arora, K.K.; Martinez-Fuentes, A.; Catt, K.J. 2003: Activation and nuclear translocation of PKCdelta, Pyk2 and ERK1/2 by gonadotropin releasing hormone in HEK293 cells. Journal of Steroid Biochemistry and Molecular Biology 85(2-5): 337-347
Guehler, S.R.; Bluestone, J.A.; Barrett, T.A. 1999: Activation and peripheral expansion of murine T-cell receptor gamma delta intraepithelial lymphocytes. Gastroenterology 116(2): 327-334
Ting, H.C.; Christian, S.L.; Burgess, A.E.; Gold, M.R. 2002: Activation and phosphatidylinositol 3-kinase-dependent phosphorylation of protein kinase C-epsilon by the B cell antigen receptor. Immunology Letters 82(3): 205-215
Mollapour, E.; Linch, D.C.; Roberts, P.J. 2001: Activation and priming of neutrophil nicotinamide adenine dinucleotide phosphate oxidase and phospholipase A(2) are dissociated by inhibitors of the kinases p42(ERK2) and p38(SAPK) and by methyl arachidonyl fluorophosphonate, the dual inhibitor of cytosolic and calcium-independent phospholipase A(2). Blood 97(8): 2469-2477
Brinchmann, J.E.; Røsok, B.I.; Spurkland, A. 1998: Activation and proliferation of CD8+ T cells in lymphoid tissues of HIV-1-infected individuals in the absence of the high-affinity IL-2 receptor. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology: Official Publication of the International Retrovirology Association 19(4): 332-338
Levine, J.M.; Reynolds, R. 1999: Activation and proliferation of endogenous oligodendrocyte precursor cells during ethidium bromide-induced demyelination. Experimental Neurology 160(2): 333-347
Kockskämper, J.; Sheehan, K.A.; Bare, D.J.; Lipsius, S.L.; Mignery, G.A.; Blatter, L.A. 2001: Activation and propagation of Ca(2+) release during excitation-contraction coupling in atrial myocytes. Biophysical Journal 81(5): 2590-2605
Vehovszky A; Elliott, C.J. 2001: Activation and reconfiguration of fictive feeding by the octopamine-containing modulatory OC interneurons in the snail Lymnaea. Journal of Neurophysiology 86(2): 792-808
Zhu, X.; Raina, A.K.; Rottkamp, C.A.; Aliev, G.; Perry, G.; Boux, H.; Smith, M.A. 2001: Activation and redistribution of c-Jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease. Journal of Neurochemistry 76(2): 435-441
Stuhlmeier, K.M. 2000: Activation and regulation of Hsp32 and Hsp70. European Journal of Biochemistry 267(4): 1161-1167
Lentsch, A.B.; Ward, P.A. 1999: Activation and regulation of NFkappaB during acute inflammation. Clinical Chemistry and Laboratory Medicine 37(3): 205-208
Sharma, S.; Mamane, Y.; Grandvaux, N.; Bartlett, J.; Petropoulos, L.; Lin, R.; Hiscott, J. 2000: Activation and regulation of interferon regulatory factor 4 in HTLV type 1-infected T lymphocytes. Aids Research and Human Retroviruses 16(16): 1613-1622
Kosaka, Y.; Calderhead, D.M.; Manning, E.M.; Hambor, J.E.; Black, A.; Geleziunas, R.; Marcu, K.B.; Noelle, R.J. 1999: Activation and regulation of the IkappaB kinase in human B cells by CD40 signaling. European Journal of Immunology 29(4): 1353-1362
Sackner-Bernstein, J.D. 2002: Activation and release of degradative proteinases within the myocardium are the trigger for ventricular remodeling in chronic heart failure. Medical Hypotheses 58(1): 18-23
Flores-Saaib, R.D.; Jia, S.; Courey, A.J. 2001: Activation and repression by the C-terminal domain of Dorsal. Development 128(10): 1869-1879
DiMario, J.X. 2002: Activation and repression of growth factor receptor gene transcription (Review). International Journal of Molecular Medicine 10(1): 65-71
Sheridan, S.D.; Opel, M.L.; Hatfield, G.W. 2001: Activation and repression of transcription initiation by a distant DNA structural transition. Molecular Microbiology 40(3): 684-690
Mariotti, R.; Bentivoglio, M. 2000: Activation and response to axotomy of microglia in the facial motor nuclei of G93A superoxide dismutase transgenic mice. Neuroscience Letters 285(2): 87-90
Hecquet, C.; Lefevre, Gëlle.; Valtink, M.; Engelmann, K.; Mascarelli, F. 2002: Activation and role of MAP kinase-dependent pathways in retinal pigment epithelial cells: ERK and RPE cell proliferation. IOVS Investigative Ophthalmology and Visual Science 43(9): 3091-3098
Hecquet, C.; Lefevre, Gëlle.; Valtink, M.; Engelmann, K.; Mascarelli, F. 2003: Activation and role of MAP kinase-dependent pathways in retinal pigment epithelium cells: JNK1, P38 kinase, and cell death. IOVS Investigative Ophthalmology and Visual Science 44(3): 1320-1329
Qiao, D.; Stratagouleas, E.D.; Martinez, J.D. 2001: Activation and role of mitogen-activated protein kinases in deoxycholic acid-induced apoptosis. Carcinogenesis 22(1): 35-41
Bruzzaniti, A.; Marx, R.; Mains, R.E. 1999: Activation and routing of membrane-tethered prohormone convertases 1 and 2. Journal of Biological Chemistry 274(35): 24703-24713
Petersson, E.; Holmdahl, R.; Butcher, G.W.; Hedlund, G. 1999: Activation and selection of NK cells via recognition of an allogeneic, non-classical MHC class I molecule, RT1-E. European Journal of Immunology 29(11): 3663-3673
Rong, W.; Spyer, K.Michael.; Burnstock, G. 2002: Activation and sensitisation of low and high threshold afferent fibres mediated by P2X receptors in the mouse urinary bladder. Journal of Physiology 541(Pt 2): 591-600
El Hanafi, D.; Bossi, L. 2000: Activation and silencing of leu-500 promoter by transcription-induced DNA supercoiling in the Salmonella chromosome. Molecular Microbiology 37(3): 583-594
Spreti, N.; Di Profio, P.; Marte, L.; Bufali, S.; Brinchi, L.; Savelli, G. 2001: Activation and stabilization of alpha-chymotrypsin by cationic additives. European Journal of Biochemistry 268(24): 6491-6497
Arroyo, M.; Torres-Guzmán, R.; de La Mata, I.; Castillón, M.P.; Acebal, C. 2000: Activation and stabilization of penicillin V acylase from streptomyces lavendulae in the presence of glycerol and glycols. Biotechnology Progress 16(3): 368-371
Lapteva, N.; Ide, K.; Nieda, M.; Ando, Y.; Hatta-Ohashi, Y.; Minami, M.; Dymshits, G.; Egawa, K.; Juji, T.; Tokunaga, K. 2002: Activation and suppression of renin-angiotensin system in human dendritic cells. Biochemical and Biophysical Research Communications 296(1): 194-200
Luttrell, L.M.; Roudabush, F.L.; Choy, E.W.; Miller, W.E.; Field, M.E.; Pierce, K.L.; Lefkowitz, R.J. 2001: Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds. Proceedings of the National Academy of Sciences of the United States of America 98(5): 2449-2454
Luttrell, L.M. 2002: Activation and targeting of mitogen-activated protein kinases by G-protein-coupled receptors. Canadian Journal of Physiology and Pharmacology 80(5): 375-382
Kim, R.; Ohi, Y.; Inoue, H.; Toge, T. 1999: Activation and the interaction of proapoptotic genes in modulating sensitivity to anticancer drugs in gastric cancer cells. International Journal of Oncology 15(4): 751-756
Shima, S.; Hérault, D.A.; Berkessel, A.; Thauer, R.K. 1998: Activation and thermostabilization effects of cyclic 2, 3-diphosphoglycerate on enzymes from the hyperthermophilic Methanopyrus kandleri. Archives of Microbiology 170(6): 469-472
Xiong, Y.-Q.; Van Wamel, W.; Nast, C.C.; Yeaman, M.R.; Cheung, A.L.; Bayer, A.S. 2002: Activation and transcriptional interaction between agr RNAIi and RNAIIi in Staphylococcus aureus in vitro and in an experimental endocarditis model. Journal of Infectious Diseases 186(5): 668-677
Ohkawara, Y.; Tamura, G.; Iwasaki, T.; Tanaka, A.; Kikuchi, T.; Shirato, K. 2000: Activation and transforming growth factor-beta production in eosinophils by hyaluronan. American Journal of Respiratory Cell and Molecular Biology 23(4): 444-451
Brand, P.; Plochmann, S.; Valk, E.; Zahn, S.; Saloga, J.; Knop, J.ür.; Becker, D. 2002: Activation and translocation of p38 mitogen-activated protein kinase after stimulation of monocytes with contact sensitizers. Journal of Investigative Dermatology 119(1): 99-106
Tao, Y-X.; Johns, R.A. 2002: Activation and up-regulation of spinal cord nitric oxide receptor, soluble guanylate cyclase, after formalin injection into the rat hind paw. Neuroscience 112(2): 439-446
Kobayashi, Y.; Arai, S.; Waku, K.; Sugiura, T. 2001: Activation by 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, of p42/44 mitogen-activated protein kinase in HL-60 cells. Journal of Biochemistry 129(5): 665-669
Yan, H-Dun.; Ishihara, K.; Serikawa, T.; Sasa, M. 2003: Activation by N-acetyl-L-aspartate of acutely dissociated hippocampal neurons in rats via metabotropic glutamate receptors. Epilepsia 44(9): 1153-1159
Alzola, E.; Pérez-Etxebarria, A.; Kabré, E.; Fogarty, D.J.; Métioui, M.; Chaïb, N.; Macarulla, J.M.; Matute, C.; Dehaye, J.P.; Marino, A. 1998: Activation by P2X7 agonists of two phospholipases A2 (PLA2) in ductal cells of rat submandibular gland. Coupling of the calcium-independent PLA2 with kallikrein secretion. Journal of Biological Chemistry 273(46): 30208-30217
Diewald, L.; Rupp, J.; Dreger, M.; Hucho, F.; Gillen, C.; Nawrath, H. 2002: Activation by acidic pH of CLC-7 expressed in oocytes from Xenopus laevis. Biochemical and Biophysical Research Communications 291(2): 421-424
Tsunenari, T.; Kurahashi, T.; Kaneko, A. 1999: Activation by bitter substances of a cationic channel in membrane patches excised from the bullfrog taste receptor cell. Journal of Physiology 519 Pt 2: 397-404
Hillrichs, S.; Schmid, R. 2001: Activation by blue light of inorganic carbon acquisition for photosynthesis in Ectocarpus siliculosus: Organic acid pools and short-term carbon fixation. European Journal of Phycology 36(1): 71-79
Mathieu, Y.; Rouet Mayer, M.A.; Barbier Brygoo, H.; Lauriere, C. 2002: Activation by fatty acids of the production of active oxygen species by tobacco cells. Plant Physiology and Biochemistry (Paris) 40(4): 313-324
Yu, H.; Matsubayashi, H.; Amano, T.; Cai, J.; Sasa, M. 2000: Activation by nicotine of striatal neurons receiving excitatory input from the substantia nigra via dopamine release. Brain Research 872(1-2): 223-226
Bacot, S.M.; Lenz, P.; Frazier-Jessen, M.R.; Feldman, G.M. 2003: Activation by prion peptide PrP106-126 induces a NF-kappaB-driven proinflammatory response in human monocyte-derived dendritic cells. Journal of Leukocyte Biology 74(1): 118-125
Vacher, C-Marie.; Frétier, P.; Créminon, C.; Calas, Aé.; Hardin-Pouzet, Hélène. 2002: Activation by serotonin and noradrenaline of vasopressin and oxytocin expression in the mouse paraventricular and supraoptic nuclei. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 22(5): 1513-1522
Kawara, T.; Derksen, R.; de Groot, J.R.; Coronel, R.; Tasseron, S.; Linnenbank, A.C.; Hauer, R.N.; Kirkels, H.; Janse, M.J.; de Bakker, J.M. 2001: Activation delay after premature stimulation in chronically diseased human myocardium relates to the architecture of interstitial fibrosis. Circulation 104(25): 3069-3075
Neely, K.E.; Hassan, A.H.; Wallberg, A.E.; Steger, D.J.; Cairns, B.R.; Wright, A.P.; Workman, J.L. 1999: Activation domain-mediated targeting of the SWI/SNF complex to promoters stimulates transcription from nucleosome arrays. Molecular Cell 4(4): 649-655
Ji, C.; Chang, W.; Centrella, M.; McCarthy, T.L. 2003: Activation domains of CCAAT enhancer binding protein delta: regions required for native activity and prostaglandin E2-dependent transactivation of insulin-like growth factor I gene expression in rat osteoblasts. Molecular Endocrinology 17(9): 1834-1843
Kato, C.; Matsuo, K.; Matsuzawa, M.; Moriya, T.; Glover, G.H.; Nakai, T. 2001: Activation during endogenous orienting of visual attention using symbolic pointers in the human parietal and frontal cortices: A functional magnetic resonance imaging study. Neuroscience Letters 314(1-2): 5-8
Schoeppe, A.; Hinz, H.J.; Gerdes, R.; Redlich, H.; Rapp, G. 1999: Activation energies and kinetics of glycolipid phase transitions. Chemistry and Physics of Lipids 103(1-2): 95-115
Kozaki Tamotsu; Saito Nobuhiko; Fujishima Atsushi; Sato Seichi; Ohashi Hiroshi 1998: Activation energy for diffusion of chloride ions in compacted sodium montmorillonite. Journal of Contaminant Hydrology 35(1-3): 67-75
Leblanc, V.; May, P. 2002: Activation et modifications post-traductionnelles de p53 apres dommage de l'ADN. M S (Medecine Sciences) 18(5): 577-584
He, B.; Kemppainen, J.A.; Voegel, J.J.; Gronemeyer, H.; Wilson, E.M. 1999: Activation function 2 in the human androgen receptor ligand binding domain mediates interdomain communication with the NH(2)-terminal domain. Journal of Biological Chemistry 274(52): 37219-37225
Zhao, Y.; Goto, K.; Saitoh, M.; Yanase, T.; Nomura, M.; Okabe, T.; Takayanagi, R.; Nawata, H. 2002: Activation function-1 domain of androgen receptor contributes to the interaction between subnuclear splicing factor compartment and nuclear receptor compartment. Identification of the p102 U5 small nuclear ribonucleoprotein particle-binding protein as a coactivator for the receptor. Journal of Biological Chemistry 277(33): 30031-30039
Goto, K.; Zhao, Y.; Saito, M.; Tomura, A.; Morinaga, H.; Nomura, M.; Okabe, T.; Yanase, T.; Takayanagi, R.; Nawata, H. 2003: Activation function-1 domain of androgen receptor contributes to the interaction between two distinct subnuclear compartments. Journal of Steroid Biochemistry and Molecular Biology 85(2-5): 201-208
Wärnmark, A.; Treuter, E.; Wright, A.P.H.; Gustafsson, J.-A. 2003: Activation functions 1 and 2 of nuclear receptors: molecular strategies for transcriptional activation. Molecular Endocrinology 17(10): 1901-1909
Oddsson, L.I.E.; De Luca, C.J. 2003: Activation imbalances in lumbar spine muscles in the presence of chronic low back pain. Journal of Applied Physiology 94(4): 1410-1420
Narayan, K.; Chumnarnsilpa, S.; Choe, H.; Irobi, E.; Urosev, D.; Lindberg, U.; Schutt, C.E.; Burtnick, L.D.; Robinson, R.C. 2003: Activation in isolation: Exposure of the actin-binding site in the C-terminal half of gelsolin does not require actin. FEBS Letters 552(2-3): 82-85
Due, D.L.; Huettel, S.A.; Hall, W.G.; Rubin, D.C. 2002: Activation in mesolimbic and visuospatial neural circuits elicited by smoking cues: evidence from functional magnetic resonance imaging. American Journal of Psychiatry 159(6): 954-960
Krings, T.; Töpper, R.; Willmes, K.; Reinges, M.H.T.; Gilsbach, J.M.; Thron, A. 2002: Activation in primary and secondary motor areas in patients with CNS neoplasms and weakness. Neurology 58(3): 381-390
Inoue, K.; Kawashima, R.; Sugiura, M.; Ogawa, A.; Schormann, T.; Zilles, K.; Fukuda, H. 2001: Activation in the ipsilateral posterior parietal cortex during tool use: a PET study. Neuroimage 14(6): 1469-1475
Bosch, M.L.; Harper, E.; Schmidt, A.; Strand, K.B.; Thormahlen, S.; Thouless, M.E.; Wang, Y. 1999: Activation in vivo of retroperitoneal fibromatosis-associated herpesvirus, a simian homologue of human herpesvirus-8. Journal of General Virology 80: 467-475
Hamann, A.; Klugewitz, K.; Austrup, F.; Jablonski-Westrich, D. 2000: Activation induces rapid and profound alterations in the trafficking of T cells. European Journal of Immunology 30(11): 3207-3218
Wegner, L.H.; De Boer, A.H. 1999: Activation kinetics of the K(+) outward rectifying conductance (KORC) in xylem parenchyma cells from barley roots. Journal of Membrane Biology 170(2): 103-119
Pincivero, D.M.; Coelho, A.J. 2000: Activation linearity and parallelism of the superficial quadriceps across the isometric intensity spectrum. Muscle and Nerve 23(3): 393-398
Waldron, R.T.; Rey, O.; Iglesias, T.; Tugal, T.; Cantrell, D.; Rozengurt, E. 2001: Activation loop Ser744 and Ser748 in protein kinase D are transphosphorylated in vivo. Journal of Biological Chemistry 276(35): 32606-32615
Pirola, L.; Zvelebil, M.J.; Bulgarelli-Leva, G.; Van Obberghen, E.; Waterfield, M.D.; Wymann, M.P. 2001: Activation loop sequences confer substrate specificity to phosphoinositide 3-kinase alpha (PI3Kalpha ). Functions of lipid kinase-deficient PI3Kalpha in signaling. Journal of Biological Chemistry 276(24): 21544-21554
Vesosky, B.; Turner, O.C.; Turner, J.; Orme, I.M. 2003: Activation marker expression on bovine peripheral blood gammadelta T cells during post-natal development and following vaccination with a commercial polyvalent viral vaccine. Developmental and Comparative Immunology 27(5): 439-447
Ariëns, R.A.S.; de Lange, M.; Snieder, H.; Boothby, M.; Spector, T.D.; Grant, P.J. 2002: Activation markers of coagulation and fibrinolysis in twins: heritability of the prethrombotic state. Lancet 359(9307): 667-671
Yoshimura, C.; Yamaguchi, M.; IIkura, M.; Izumi, S.; Kudo, K.; Nagase, H.; Ishii, A.; Walls, A.F.; Ra, C.; Iwata, T.; Igarashi, T.; Yamamoto, K.; Hirai, K. 2002: Activation markers of human basophils: CD69 expression is strongly and preferentially induced by IL-3. Journal of Allergy and Clinical Immunology 109(5): 817-823
Nishida, M.; Schey, K.L.; Takagahara, S.; Kontani, K.; Katada, T.; Urano, Y.; Nagano, T.; Nagao, T.; Kurose, H. 2002: Activation mechanism of Gi and go by reactive oxygen species. Journal of Biological Chemistry 277(11): 9036-9042
Kim, D.Ryoung.; Lee, I.; Ha, S.Chul.; Kim, K.Kyu. 2003: Activation mechanism of HSP16.5 from Methanococcus jannaschii. Biochemical and Biophysical Research Communications 307(4): 991-998
Kudo, T-aki.; Sakamoto, Y.; Tamura, S.; Kobayashi, T. 2003: Activation mechanism of c-Jun amino-terminal kinase in the course of endodermal differentiation of P19 embryonic carcinoma cells. FEBS Letters 539(1-3): 29-33
Fanelli, F.; Barbier, P.; Zanchetta, D.; de Benedetti, P.G.; Chini, B. 1999: Activation mechanism of human oxytocin receptor: a combined study of experimental and computer-simulated mutagenesis. Molecular Pharmacology 56(1): 214-225
Ge, G.; Wu, J.; Wang, Y.; Lin, Q. 2002: Activation mechanism of solubilized epidermal growth factor receptor tyrosine kinase. Biochemical and Biophysical Research Communications 290(3): 914-920
Coyle, C.M.; Puranik, M.; Youn, H.; Nielsen, S.B.øn.; Williams, R.D.; Kerby, R.L.; Roberts, G.P.; Spiro, T.G. 2003: Activation mechanism of the CO sensor CooA. Mutational and resonance Raman spectroscopic studies. Journal of Biological Chemistry 278(37): 35384-35393
Freel Meyers, C.L.; Borch, R.F. 2000: Activation mechanisms of nucleoside phosphoramidate prodrugs. Journal of Medicinal Chemistry 43(22): 4319-4327
Shirai, Y.; Saito, N. 2002: Activation mechanisms of protein kinase C: maturation, catalytic activation, and targeting. Journal of Biochemistry 132(5): 663-668
Ried, S.; Jäger, C.; Jeffers, M.; Vande Woude, G.F.; Graeff, H.; Schmitt, M.; Lengyel, E. 1999: Activation mechanisms of the urokinase-type plasminogen activator promoter by hepatocyte growth factor/scatter factor. Journal of Biological Chemistry 274(23): 16377-16386
Anderson, R.F.; Shinde, S.S.; Hay, M.P.; Gamage, S.A.; Denny, W.A. 2003: Activation of 3-amino-1,2,4-benzotriazine 1,4-dioxide antitumor agents to oxidizing species following their one-electron reduction. Journal of the American Chemical Society 125(3): 748-756
Arlt, V.M.; Glatt, H.; Muckel, E.; Pabel, U.; Sorg, B.L.; Seidel, A.; Frank, H.; Schmeiser, H.H.; Phillips, D.H. 2003: Activation of 3-nitrobenzanthrone and its metabolites by human acetyltransferases, sulfotransferases and cytochrome P450 expressed in Chinese hamster V79 cells. International Journal of Cancer 105(5): 583-592
Zou, M.-H.; Hou, X.-Y.; Shi, C.-M.; Kirkpatick, S.; Liu, F.; Goldman, M.H.; Cohen, R.A. 2003: Activation of 5'-AMP-activated kinase is mediated through c-Src and phosphoinositide 3-kinase activity during hypoxia-reoxygenation of bovine aortic endothelial cells. Role of peroxynitrite. Journal of Biological Chemistry 278(36): 34003-34010
Lambert, H.W.; Weiss, E.R.; Lauder, J.M. 2001: Activation of 5-HT receptors that stimulate the adenylyl cyclase pathway positively regulates IGF-i in cultured craniofacial mesenchymal cells. Developmental Neuroscience 23(1): 70-77
Yoshitake, T.; Yoshitake, S.; Yamaguchi, M.; Ogren, S.O.; Kehr, J. 2003: Activation of 5-HT(1A) autoreceptors enhances the inhibitory effect of galanin on hippocampal 5-HT release in vivo. Neuropharmacology 44(2): 206-213
Kannari, K.; Yamato, H.; Shen, H.; Tomiyama, M.; Suda, T.; Matsunaga, M. 2001: Activation of 5-HT(1A) but not 5-HT(1B) receptors attenuates an increase in extracellular dopamine derived from exogenously administered L-DOPA in the striatum with nigrostriatal denervation. Journal of Neurochemistry 76(5): 1346-1353
Fletcher, P.J.; Korth, K.M. 1999: Activation of 5-HT1B receptors in the nucleus accumbens reduces amphetamine-induced enhancement of responding for conditioned reward. Psychopharmacology 142(2): 165-174
Fletcher, P.J.; Azampanah, A.; Korth, K.M. 2002: Activation of 5-HT(1B) receptors in the nucleus accumbens reduces self-administration of amphetamine on a progressive ratio schedule. Pharmacology Biochemistry and Behavior 71(4): 717-725
Yan, Q.S.; Yan, S.E. 2001: Activation of 5-HT(1B/1D) receptors in the mesolimbic dopamine system increases dopamine release from the nucleus accumbens: a microdialysis study. European Journal of Pharmacology 418(1-2): 55-64
Darvesh, A.S.; Gudelsky, G.A. 2003: Activation of 5-HT2 receptors induces glycogenolysis in the rat brain. European Journal of Pharmacology 464(2-3): 135-140
Koskinen, T.; Ruotsalainen, S.; Puumala, T.; Lappalainen, R.; Koivisto, E.; Männistö, P.T.; Sirviö, J. 2000: Activation of 5-HT2A receptors impairs response control of rats in a five-choice serial reaction time task. Neuropharmacology 39(3): 471-481
Yan, Q.S. 2000: Activation of 5-HT2A/2C receptors within the nucleus accumbens increases local dopaminergic transmission. Brain Research Bulletin 51(1): 75-81
Grottick, A.J.; Corrigall, W.A.; Higgins, G.A. 2001: Activation of 5-HT(2C) receptors reduces the locomotor and rewarding effects of nicotine. Psychopharmacology 157(3): 292-298
Lenglet, S.; Louiset, E.; Delarue, C.; Vaudry, H.; Contesse, V. 2002: Activation of 5-HT(7) receptor in rat glomerulosa cells is associated with an increase in adenylyl cyclase activity and calcium influx through T-type calcium channels. Endocrinology 143(5): 1748-1760
Maccarrone, M.; Taccone-Gallucci, M.; Meloni, C.; Cococcetta, N.; Di Villahermosa, S.M.; Casciani, C.U.; Finazzi-Agrò, A. 1999: Activation of 5-lipoxygenase and related cell membrane lipoperoxidation in hemodialysis patients. Journal of the American Society of Nephrology: Jasn 10(9): 1991-1996
Werz, O.; Bürkert, E.; Samuelsson, B.; Rådmark, O.; Steinhilber, D. 2002: Activation of 5-lipoxygenase by cell stress is calcium independent in human polymorphonuclear leukocytes. Blood 99(3): 1044-1052
Berger, A.J.; Huynh, P. 2002: Activation of 5HT1B receptors inhibits glycinergic synaptic inputs to mammalian motoneurons during postnatal development. Brain Research 956(2): 380-384
Nariya, H.; Inouye, S. 2002: Activation of 6-phosphofructokinase via phosphorylation by Pkn4, a protein Ser/Thr kinase of Myxococcus xanthus. Molecular Microbiology 46(5): 1353-1366
DeFazio, R.A.; Heger, S.; Ojeda, S.R.; Moenter, S.M. 2002: Activation of A-type gamma-aminobutyric acid receptors excites gonadotropin-releasing hormone neurons. Molecular Endocrinology 16(12): 2872-2891
Reshkin, S.J.; Guerra, L.; Bagorda, A.; Debellis, L.; Cardone, R.; Li, A.H.; Jacobson, K.A.; Casavola, V. 2000: Activation of A(3) adenosine receptor induces calcium entry and chloride secretion in A(6) cells. Journal of Membrane Biology 178(2): 103-113
Loechel, F.; Wewer, U.M. 2001: Activation of ADAM 12 protease by copper. FEBS Letters 506(1): 65-68
Kitabayashi, I.; Aikawa, Y.; Nguyen, L.A.; Yokoyama, A.; Ohki, M. 2001: Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein. EMBO Journal 20(24): 7184-7196
Winder, W.W.; Holmes, B.F.; Rubink, D.S.; Jensen, E.B.; Chen, M.; Holloszy, J.O. 2000: Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. Journal of Applied Physiology 88(6): 2219-2226
Horman, S.; Browne, G.; Krause, U.; Patel, J.; Vertommen, D.; Bertrand, L.; Lavoinne, A.; Hue, L.; Proud, C.; Rider, M. 2002: Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis. Current Biology: Cb 12(16): 1419-1423
Wei, D.; Williams, D.; Browder, W. 2002: Activation of AP-1 and SP1 correlates with wound growth factor gene expression in glucan-treated human fibroblasts. International Immunopharmacology 2(8): 1163-1172
Vollgraf, U.; Wegner, M.; Richter-Landsberg, C. 1999: Activation of AP-1 and nuclear factor-kappaB transcription factors is involved in hydrogen peroxide-induced apoptotic cell death of oligodendrocytes. Journal of Neurochemistry 73(6): 2501-2509
Gannett, P.M.; Ye, J.; Ding, M.; Powell, J.; Zhang, Y.; Darian, E.; Daft, J.; Shi, X. 2000: Activation of AP-1 through the MAP kinase pathway: A potential mechanism of the carcinogenic effect of arenediazonium ions. Chemical Research in Toxicology 13(10): 1020-1027
Ichikawa, H.T.; Williams, L.P.; Segal, B.M. 2002: Activation of APCs through CD40 or Toll-like receptor 9 overcomes tolerance and precipitates autoimmune disease. Journal of Immunology 169(5): 2781-2787
Hsieh, M.M.; Hegde, V.; Kelley, M.R.; Deutsch, W.A. 2001: Activation of APE/Ref-1 redox activity is mediated by reactive oxygen species and PKC phosphorylation. Nucleic Acids Research 29(14): 3116-3122
Matrougui, K.; Loufrani, L.; Heymes, C.; Lévy, B.I.; Henrion, D. 1999: Activation of AT(2) receptors by endogenous angiotensin Ii is involved in flow-induced dilation in rat resistance arteries. Hypertension 34(4 Part 1): 659-665
Wang, Y.; Shen, J.; Arenzana, N.; Tirasophon, W.; Kaufman, R.J.; Prywes, R. 2000: Activation of ATF6 and an ATF6 DNA binding site by the endoplasmic reticulum stress response. Journal of Biological Chemistry 275(35): 27013-27020
Sorimachi, M.; Moritoyo, T.; Yamagami, K. 2000: Activation of ATP receptor increases the cytosolic Ca(2+) concentration in nucleus accumbens neurons of rat brain. Brain Research 882(1-2): 217-220
Sorimachi, M.; Yamagami, K.; Wakomori, M. 2002: Activation of ATP receptor increases the cytosolic Ca(2+) concentration in ventral tegmental area neurons of rat brain. Brain Research 935(1-2): 129-133
Fujita, A.; Matsuoka, T.; Matsushita, K.; Kurachi, Y. 2001: Activation of ATP-sensitive K+ channels by ADP and K+ channel openers: homology model of sulfonylurea receptor carboxyl-termini. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 118(3): 177-186
Lu, T.; Hoshi, T.; Weintraub, N.L.; Spector, A.A.; Lee, H.C. 2001: Activation of ATP-sensitive K(+) channels by epoxyeicosatrienoic acids in rat cardiac ventricular myocytes. Journal of Physiology 537(Pt 3): 811-827
Soares, A.C.; Leite, R.; Tatsuo, M.A.; Duarte, I.D. 2000: Activation of ATP-sensitive K(+) channels: mechanism of peripheral antinociceptive action of the nitric oxide donor, sodium nitroprusside. European Journal of Pharmacology 400(1): 67-71
Han, J.; Kim, N.; Kim, E.; Kim, S.; Cho, K. 2001: Activation of ATP-sensitive potassium channels by the predominant metabolite of isoflurane in rabbit ventricular myocytes. Korean Journal of Physiology and Pharmacology 5(2): 165-175
Lorite, M.J.; Smith, H.J.; Arnold, J.A.; Morris, A.; Thompson, M.G.; Tisdale, M.J. 2001: Activation of ATP-ubiquitin-dependent proteolysis in skeletal muscle in vivo and murine myoblasts in vitro by a proteolysis-inducing factor (PIF). British Journal of Cancer 85(2): 297-302
Leung, J.Y.; Kolligs, F.T.; Wu, R.; Zhai, Y.; Kuick, R.; Hanash, S.; Cho, K.R.; Fearon, E.R. 2002: Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling. Journal of Biological Chemistry 277(24): 21657-21665
Swift, L.P.; Cutts, S.M.; Rephaeli, A.; Nudelman, A.; Phillips, D.R. 2003: Activation of adriamycin by the pH-dependent formaldehyde-releasing prodrug hexamethylenetetramine. Molecular Cancer Therapeutics 2(2): 189-198
Hutchinson, J.; Jin, J.; Cardiff, R.D.; Woodgett, J.R.; Muller, W.J. 2001: Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression. Molecular and Cellular Biology 21(6): 2203-2212
Mockridge, J.W.; Marber, M.S.; Heads, R.J. 2000: Activation of Akt during simulated ischemia/reperfusion in cardiac myocytes. Biochemical and Biophysical Research Communications 270(3): 947-952
Krieg, T.; Landsberger, M.; Alexeyev, M.F.; Felix, S.B.; Cohen, M.V.; Downey, J.M. 2003: Activation of Akt is essential for acetylcholine to trigger generation of oxygen free radicals. Cardiovascular Research 58(1): 196-202
Bang, O.S.; Ha, B.G.; Park, E.K.; Kang, S.S. 2000: Activation of Akt is induced by heat shock and involved in suppression of heat-shock-induced apoptosis of NIH3T3 cells. Biochemical and Biophysical Research Communications 278(2): 306-311
Dong, F.; Larner, A.C. 2000: Activation of Akt kinase by granulocyte colony-stimulating factor (G-CSF): evidence for the role of a tyrosine kinase activity distinct from the Janus kinases. Blood 95(5): 1656-1662
Matsuzaki, H.; Tamatani, M.; Mitsuda, N.; Namikawa, K.; Kiyama, H.; Miyake, S.; Tohyama, M. 1999: Activation of Akt kinase inhibits apoptosis and changes in Bcl-2 and Bax expression induced by nitric oxide in primary hippocampal neurons. Journal of Neurochemistry 73(5): 2037-2046
Yano, S.; Morioka, M.; Fukunaga, K.; Kawano, T.; Hara, T.; Kai, Y.; Hamada, J.; Miyamoto, E.; Ushio, Y. 2001: Activation of Akt/protein kinase B contributes to induction of ischemic tolerance in the CA1 subfield of gerbil hippocampus. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 21(4): 351-360
Steele-Mortimer, O.; Knodler, L.A.; Marcus, S.L.; Scheid, M.P.; Goh, B.; Pfeifer, C.G.; Duronio, V.; Finlay, B.B. 2000: Activation of Akt/protein kinase B in epithelial cells by the Salmonella typhimurium effector sigD. Journal of Biological Chemistry 275(48): 37718-37724
Kandel, E.S.; Skeen, J.; Majewski, N.; Di Cristofano, A.; Pandolfi, P.Paolo.; Feliciano, C.S.; Gartel, A.; Hay, N. 2002: Activation of Akt/protein kinase B overcomes a G(2)/m cell cycle checkpoint induced by DNA damage. Molecular and Cellular Biology 22(22): 7831-7841
Hsu, E.H.; Lochan, A.C.; Cowen, D.S. 2001: Activation of Akt1 by human 5-hydroxytryptamine (serotonin)1B receptors is sensitive to inhibitors of MEK. Journal of Pharmacology and Experimental Therapeutics 298(2): 825-832
Kunizuka, H.; Kinouchi, H.; Arai, S.; Izaki, K.; Mikawa, S.; Kamii, H.; Sugawara, T.; Suzuki, A.; Mizoi, K.; Yoshimoto, T. 1999: Activation of Arc gene, a dendritic immediate early gene, by middle cerebral artery occlusion in rat brain. Neuroreport 10(8): 1717-1722
Le Clainche, C.; Didry, D.; Carlier, M.F.; Pantaloni, D. 2001: Activation of Arp2/3 complex by Wiskott-Aldrich Syndrome protein is linked to enhanced binding of ATP to Arp2. Journal of Biological Chemistry 276(50): 46689-46692
Antonelli, V.; Bernasconi, F.; Wong, Y.H.; Vallar, L. 2000: Activation of B-Raf and regulation of the mitogen-activated protein kinase pathway by the G(o) alpha chain. Molecular Biology of the Cell 11(4): 1129-1142
Zhang, B.H.; Guan, K.L. 2000: Activation of B-Raf kinase requires phosphorylation of the conserved residues Thr598 and Ser601. EMBO Journal 19(20): 5429-5439
Park, T-Ju.; Kim, K-Tai. 2003: Activation of B2 bradykinin receptors by neurotensin. Cellular Signalling 15(5): 519-527
Gilmore, A.P.; Valentijn, A.J.; Wang, P.; Ranger, A.M.; Bundred, N.; O'Hare, M.J.; Wakeling, A.; Korsmeyer, S.J.; Streuli, C.H. 2002: Activation of BAD by therapeutic inhibition of epidermal growth factor receptor and transactivation by insulin-like growth factor receptor. Journal of Biological Chemistry 277(31): 27643-27650
Prakriya, M.; Lingle, C.J. 2000: Activation of BK channels in rat chromaffin cells requires summation of Ca(2+) influx from multiple Ca(2+) channels. Journal of Neurophysiology 84(3): 1123-1135
Hayashi, Y.; Iwashita, T.; Murakamai, H.; Kato, Y.; Kawai, K.; Kurokawa, K.; Tohnai, I.; Ueda, M.; Takahashi, M. 2001: Activation of BMK1 via tyrosine 1062 in RET by GDNF and MEN2A mutation. Biochemical and Biophysical Research Communications 281(3): 682-689
Panaretakis, T.; Pokrovskaja, K.; Shoshan, M.C.; Grandér, D. 2002: Activation of Bak, Bax, and BH3-only proteins in the apoptotic response to doxorubicin. Journal of Biological Chemistry 277(46): 44317-44326
Wang, Z.; Morris, G.F.; Reed, J.C.; Kelly, G.D.; Morris, C.B. 1999: Activation of Bcl-2 promoter-directed gene expression by the human immunodeficiency virus type-1 Tat protein. Virology 257(2): 502-510
Henshall, D.C.; Araki, T.; Schindler, C.K.; Lan, J-Quan.; Tiekoter, K.L.; Taki, W.; Simon, R.P. 2002: Activation of Bcl-2-associated death protein and counter-response of Akt within cell populations during seizure-induced neuronal death. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 22(19): 8458-8465
Caplan, D.; Alpert, N.; Waters, G.; Olivieri, A. 2000: Activation of Broca's area by syntactic processing under conditions of concurrent articulation. Human Brain Mapping 9(2): 65-71
Yaqub, S.; Abrahamsen, H.; Zimmerman, B.; Kholod, N.; Torgersen, K.Martin.; Mustelin, T.; Herberg, F.W.; Taskén, K.; Vang, T. 2003: Activation of C-terminal Src kinase (Csk) by phosphorylation at serine-364 depends on the Csk-Src homology 3 domain. Biochemical Journal 372(Pt 1): 271-278
Ichiba, T.; Hashimoto, Y.; Nakaya, M.; Kuraishi, Y.; Tanaka, S.; Kurata, T.; Mochizuki, N.; Matsuda, M. 1999: Activation of C3G guanine nucleotide exchange factor for Rap1 by phosphorylation of tyrosine 504. Journal of Biological Chemistry 274(20): 14376-14381
Beinfeld, M.C.; Connolly, K. 2001: Activation of CB1 cannabinoid receptors in rat hippocampal slices inhibits potassium-evoked cholecystokinin release, a possible mechanism contributing to the spatial memory defects produced by cannabinoids. Neuroscience Letters 301(1): 69-71
Kim, D.J.; Thayer, S.A. 2000: Activation of CB1 cannabinoid receptors inhibits neurotransmitter release from identified synaptic sites in rat hippocampal cultures. Brain Research 852(2): 398-405
Govaerts, C.éd.; Bondue, A.; Springael, J.-Y.; Olivella, M.; Deupi, X.; Le Poul, E.; Wodak, S.J.; Parmentier, M.; Pardo, L.; Blanpain, C.éd. 2003: Activation of CCR5 by chemokines involves an aromatic cluster between transmembrane helices 2 and 3. Journal of Biological Chemistry 278(3): 1892-1903
Lee, W.H.; Lee, Y.; Jeong, J.O.; Lee, S.Y.; Choi, Y.H.; Park, J.E. 2001: Activation of CD14 on circulating monocytes in patients with acute coronary syndrome. International Journal of Cardiology 80(2-3): 135-142
de Jersey, J.; Carmignac, D.; Barthlott, T.; Robinson, I.; Stockinger, B. 2002: Activation of CD8 T cells by antigen expressed in the pituitary gland. Journal of Immunology 169(12): 6753-6759
Kitchen, S.G.; LaForge, S.; Patel, V.P.; Kitchen, C.M.; Miceli, M.C.; Zack, J.A. 2002: Activation of CD8 T cells induces expression of CD4, which functions as a chemotactic receptor. Blood 99(1): 207-212
Dyrhol-Riise, A.M.; Voltersvik, P.; Olofsson, J.; Asjö, B. 1999: Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection. Aids 13(17): 2365-2376
Kakugawa, K.; Hattori, M.; Beauchemin, N.; Minato, N. 2003: Activation of CEA-CAM-1-mediated cell adhesion via CD98: involvement of PKCdelta. Febs Letters 552(2-3): 184-188
Niisato, N.; Nishio, K.; Marunaka, Y. 2002: Activation of CFTR Cl(-) channel by tyrphostins via a protein tyrosine kinase-independent pathway in forskolin-stimulated renal epithelial A6 cells. Life Sciences 71(10): 1199-1207
Jasmin, L.; Janni, G.; Manz, H.J.; Rabkin, S.D. 1998: Activation of CNS circuits producing a neurogenic cystitis: evidence for centrally induced peripheral inflammation. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 18(23): 10016-10029
Morton, C.L.; Wierdl, M.; Oliver, L.; Ma, M.K.; Danks, M.K.; Stewart, C.F.; Eiseman, J.L.; Potter, P.M. 2000: Activation of CPT-11 in mice: identification and analysis of a highly effective plasma esterase. Cancer Research 60(15): 4206-4210
Lutz, M.A.; Correll, P.H. 2003: Activation of CR3-mediated phagocytosis by MSP requires the RON receptor, tyrosine kinase activity, phosphatidylinositol 3-kinase, and protein kinase C zeta. Journal of Leukocyte Biology 73(6): 802-814
Banchio, C.; Schang, L.M.; Vance, D.E. 2003: Activation of CTP:phosphocholine cytidylyltransferase alpha expression during the S phase of the cell cycle is mediated by the transcription factor Sp1. Journal of Biological Chemistry 278(34): 32457-32464
Hutzler, J.Matthew.; Kolwankar, D.; Hummel, M.A.; Tracy, T.S. 2002: Activation of CYP2C9-mediated metabolism by a series of dapsone analogs: kinetics and structural requirements. Drug Metabolism and Disposition: the Biological Fate of Chemicals 30(11): 1194-1200
Karatepe, N.; Ersoy-Mericboyu, A.; Kucukbayrak, S. 1999: Activation of Ca(OH)2 using different siliceous materials. Environmental Technology 20(4): 377-385
Shimano, M.; Nakaya, Y.; Fukui, R.; Kamada, M.; Hamada, Y.; Maeda, K.; Aono, T. 2000: Activation of Ca2+-activated K+ channels in human myometrium by nitric oxide. Gynecologic and Obstetric Investigation 49(4): 249-254
Shiells, R.A.; Falk, G. 2000: Activation of Ca2+--calmodulin kinase II induces desensitization by background light in dogfish retinal 'on' bipolar cells. Journal of Physiology 528 Pt 2: 327-338
Göpel, S.O.; Kanno, T.; Barg, S.; Eliasson, L.; Galvanovskis, J.; Renström, E.; Rorsman, P. 1999: Activation of Ca(2+)-dependent K(+) channels contributes to rhythmic firing of action potentials in mouse pancreatic beta cells. Journal of General Physiology 114(6): 759-770
Repp, H.; Koschinski, A.; Decker, K.; Dreyer, F. 1998: Activation of a Ca2+-dependent K+ current in mouse fibroblasts by lysophosphatidic acid requires a pertussis toxin-sensitive G protein and Ras. Naunyn-Schmiedeberg's Archives of Pharmacology 358(5): 509-517
Fraser, H.; Davidge, S.T.; Clanachan, A.S. 2000: Activation of Ca(2+)-independent nitric oxide synthase by 17beta-estradiol in post-ischemic rat heart. Cardiovascular Research 46(1): 111-118
Kuruma, A.; Hiraoka, M.; Kawano, S. 1998: Activation of Ca2+-sensitive Cl- current by reverse mode Na+/Ca2+ exchange in rabbit ventricular myocytes. Pflugers Archiv: European Journal of Physiology 436(6): 976-983
Uezu, A.; Fukunaga, K.; Kasahara, J.; Miyamoto, E. 2002: Activation of Ca2+/calmodulin-dependent protein kinase I in cultured rat hippocampal neurons. Journal of Neurochemistry 82(3): 585-593
Inagaki, N.; Nishizawa, M.; Arimura, N.; Yamamoto, H.; Takeuchi, Y.; Miyamoto, E.; Kaibuchi, K.; Inagaki, M. 2000: Activation of Ca2+/calmodulin-dependent protein kinase Ii within post-synaptic dendritic spines of cultured hippocampal neurons. Journal of Biological Chemistry 275(35): 27165-27171
Kasahara, J.; Fukunaga, K.; Miyamoto, E. 2000: Activation of CA(2+)/calmodulin-dependent protein kinase IV in cultured rat hippocampal neurons. Journal of Neuroscience Research 59(5): 594-600
Masuya, N. 2002: Activation of Cdc2 kinase induced by okadaic acid without the dephosphorylation of Cdc2 on tyrosine 15. Japanese Journal of Fertility and Sterility 47(1): 1-12
Royal, I.; Lamarche-Vane, N.; Lamorte, L.; Kaibuchi, K.; Park, M. 2000: Activation of cdc42, rac, PAK, and rho-kinase in response to hepatocyte growth factor differentially regulates epithelial cell colony spreading and dissociation. Molecular Biology of the Cell 11(5): 1709-1725
Sudo, T.; Ota, Y.; Kotani, S.; Nakao, M.; Takami, Y.; Takeda, S.; Saya, H. 2001: Activation of Cdh1-dependent APC is required for G1 cell cycle arrest and DNA damage-induced G2 checkpoint in vertebrate cells. EMBO Journal 20(22): 6499-6508
Williams, O.; Gil-Gómez, G.; Norton, T.; Kioussis, D.; Brady, H.J. 2000: Activation of Cdk2 is a requirement for antigen-mediated thymic negative selection. European Journal of Immunology 30(2): 709-713
Jaumot, M.; Estanyol, J.M.; Serratosa, J.; Agell, N.; Bachs, O. 1999: Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes. Hepatology 29(2): 385-395
Appleby, J.L.; Bourret, R.B. 1999: Activation of CheY mutant D57N by phosphorylation at an alternative site, Ser-56. Molecular Microbiology 34(5): 915-925
Niisato, N.; Ito, Y.; Marunaka, Y. 1999: Activation of Cl- channel and Na+/K+/2Cl- cotransporter in renal epithelial A6 cells by flavonoids: genistein, daidzein, and apigenin. Biochemical and Biophysical Research Communications 254(2): 368-371
Himmel, K.L.; Bi, F.; Shen, H.; Jenkins, N.A.; Copeland, N.G.; Zheng, Y.; Largaespada, D.A. 2002: Activation of clg, a novel dbl family guanine nucleotide exchange factor gene, by proviral insertion at evi24, a common integration site in B cell and myeloid leukemias. Journal of Biological Chemistry 277(16): 13463-13472
Izquierdo-Claros, R.M.; del Boyano-Adánez, M.; Arilla-Ferreiro, E. 2000: Activation of D1 and D2 dopamine receptors increases the activity of the somatostatin receptor-effector system in the rat frontoparietal cortex. Journal of Neuroscience Research 62(1): 91-98
Jiang, M.R.; Yang, Y.; Wu, J.R. 2001: Activation of DNA damage checkpoints in CHO cells requires a certain level of DNA damage. Biochemical and Biophysical Research Communications 287(3): 775-780
Stagljar, I.; Hübscher, U.; Barberis, A. 1999: Activation of DNA replication in yeast by recruitment of the RNA polymerase Ii transcription complex. Biological Chemistry 380(5): 525-530
Tamura, M.; Yanagihara, N.; Tanaka, H.; Osajima, A.; Hirano, T.; Higashi, K.; Yamada, K.M.; Nakashima, Y.; Hirano, H. 2000: Activation of DNA synthesis and AP-1 by profilin, an actin-binding protein, via binding to a cell surface receptor in cultured rat mesangial cells. Journal of the American Society of Nephrology: Jasn 11(9): 1620-1630
Scovassi, A.I.; Torriglia, A. 2003: Activation of DNA-degrading enzymes during apoptosis. European Journal of Histochemistry: Ejh 47(3): 185-194
Hammarsten, O.; Defazio, L.G.; Chu, G. 2000: Activation of DNA-dependent protein kinase by single-stranded DNA ends. Journal of Biological Chemistry 275(3): 1541-1550
Chakravarthy, B.R.; Walker, T.; Rasquinha, I.; Hill, I.E.; Macmanus, J.P. 1999: Activation of DNA-dependent protein kinase may play a role in apoptosis of human neuroblastoma cells. Journal of Neurochemistry 72(3): 933-942
Hoffmann, M.; Schmidt, M.; Wels, W. 1998: Activation of EGF receptor family members suppresses the cytotoxic effects of tumor necrosis factor-alpha. Cancer Immunology Immunotherapy: Cii 47(3): 167-175
Huang, Y-Chin.T.; Wu, W.; Ghio, A.J.; Carter, J.D.; Silbajoris, R.; Devlin, R.B.; Samet, J.M. 2002: Activation of EGF receptors mediates pulmonary vasoconstriction induced by residual oil fly ash. Experimental Lung Research 28(1): 19-38
Mao, X.; Fujiwara, Y.; Chapdelaine, A.; Yang, H.; Orkin, S.H. 2001: Activation of EGFP expression by Cre-mediated excision in a new ROSA26 reporter mouse strain. Blood 97(1): 324-326
Masuda, K.; Shima, H.; Katagiri, C.; Kikuchi, K. 2003: Activation of ERK induces phosphorylation of MAPK phosphatase-7, a JNK specific phosphatase, at Ser-446. Journal of Biological Chemistry 278(34): 32448-32456
Schafe, G.E.; Atkins, C.M.; Swank, M.W.; Bauer, E.P.; Sweatt, J.D.; LeDoux, J.E. 2000: Activation of ERK/MAP kinase in the amygdala is required for memory consolidation of pavlovian fear conditioning. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 20(21): 8177-8187
Walowitz, J.L.; Roth, J.A. 1999: Activation of ERK1 and ERK2 is required for manganese-induced neurite outgrowth in rat pheochromocytoma (PC12) cells. Journal of Neuroscience Research 57(6): 847-854
Wang, X.; Zhu, C.; Qiu, L.; Hagberg, H.; Sandberg, M.; Blomgren, K. 2003: Activation of ERK1/2 after neonatal rat cerebral hypoxia-ischaemia. Journal of Neurochemistry 86(2): 351-362
Lüschen, S.; Adam, D.; Ussat, S.; Kreder, D.; Schneider-Brachert, W.; Krönke, M.; Adam-Klages, S. 2000: Activation of ERK1/2 and cPLA(2) by the p55 TNF receptor occurs independently of FAN. Biochemical and Biophysical Research Communications 274(2): 506-512
Chen, Z.; Rola-Pleszczynski, M.; Stankova, J. 2003: Activation of ERK1/2 by platelet-activating factor receptor is independent of receptor internalisation and G-protein activation. Cellular Signalling 15(9): 843-850
Chen, W.; Monick, M.M.; Carter, A.B.; Hunninghake, G.W. 2000: Activation of ERK2 by respiratory syncytial virus in A549 cells is linked to the production of interleukin 8. Experimental Lung Research 26(1): 13-26
Matsui, T.; Yonemura, S.; Tsukita, S.; Tsukita, S. 1999: Activation of ERM proteins in vivo by Rho involves phosphatidyl-inositol 4-phosphate 5-kinase and not ROCK kinases. Current Biology: Cb 9(21): 1259-1262
Suzukawa, K.; Kodera, T.; Shimizu, S.; Nagasawa, T.; Asou, H.; Kamada, N.; Taniwaki, M.; Yokota, J.; Morishita, K. 1999: Activation of EVI1 transcripts with chromosomal translocation joining the TCRVbeta locus and the EVI1 gene in human acute undifferentiated leukemia cell line (Kasumi-3) with a complex translocation of der(3)t(3;7;8). Leukemia 13(9): 1359-1366
Woods, T.C.; Blystone, C.R.; Yoo, J.; Edelman, E.R. 2002: Activation of EphB2 and its ligands promotes vascular smooth muscle cell proliferation. Journal of Biological Chemistry 277(3): 1924-1927
Barel, M.; Balbo, M.; Le Romancer, M.; Frade, R. 2003: Activation of Epstein-Barr virus/C3d receptor (gp140, CR2, CD21) on human cell surface triggers pp60src and Akt-GSK3 activities upstream and downstream to PI 3-kinase, respectively. European journal of immunology 33(9): 2557-2566
Watts, S.W.; Yang, P.; Banes, A.K.; Baez, M. 2001: Activation of Erk mitogen-activated protein kinase proteins by vascular serotonin receptors. Journal of Cardiovascular Pharmacology 38(4): 539-551
Jiang, Z.; Zhang, Y.; Chen, X.; Lam, P.Y.; Yang, H.; Xu, Q.; Yu, A.C.H. 2002: Activation of Erk1/2 and Akt in astrocytes under ischemia. Biochemical and Biophysical Research Communications 294(3): 726-733
Sipeki, S.; Bander, Eébet.; Ways, D.Kirk.; Faragó, A. 2002: Activation of Erk1/Erk2 and transiently increased p53 levels together may account for p21 expression associated with phorbol ester-induced transient growth inhibition in HepG2 cells. Cellular Signalling 14(2): 115-121
Pierce, K.L.; Fujino, H.; Srinivasan, D.; Regan, J.W. 1999: Activation of FP prostanoid receptor isoforms leads to Rho-mediated changes in cell morphology and in the cell cytoskeleton. Journal of Biological Chemistry 274(50): 35944-35949
Jamieson, E.; Jeffrey, M.; Ironside, J.W.; Fraser, J.R. 2001: Activation of Fas and caspase 3 precedes PrP accumulation in 87V scrapie. Neuroreport 12(16): 3567-3572
Schett, G.; Steiner, C.W.; Gröger, M.; Winkler, S.; Graninger, W.; Smolen, J.; Xu, Q.; Steiner, G. 1999: Activation of Fas inhibits heat-induced activation of HSF1 and up-regulation of hsp70. FASEB Journal 13(8): 833-842
Oak, M.H.; Cheong, H.; Kim, K.M. 1999: Activation of Fc epsilon Ri inhibits the pyruvate kinase through direct interaction with the gamma-chain. International Archives of Allergy and Immunology 119(2): 95-100
Remmers, A.E.; Clark, M.J.; Alt, A.; Medzihradsky, F.; Woods, J.H.; Traynor, J.R. 2000: Activation of G protein by opioid receptors: Role of receptor number and G-protein concentration. European Journal of Pharmacology 396(2-3): 67-75
Odagaki, Y.; Nishi, N.; Nakagawa, S.; Koyama, T. 1999: Activation of G proteins by neuropeptide y and gamma-aminobutyric acid(B) receptor agonists in rat cerebral cortical membranes through distinct modes of action. Journal of Pharmacology and Experimental Therapeutics 291(3): 1250-1256
Cherfils, J.; Chabre, M. 2003: Activation of G-protein Galpha subunits by receptors through Galpha-Gbeta and Galpha-Ggamma interactions. Trends in Biochemical Sciences 28(1): 13-17
Mizoguchi, H.; Narita, M.; Nagase, H.; Tseng, L.F. 2000: Activation of G-proteins in the mouse pons/medulla by beta-endorphin is mediated by the stimulation of mu- and putative epsilon-receptors. Life Sciences 67(22): 2733-2743
Callera, J.C.; Bonagamba, L.G.; Nosjean, A.; Laguzzi, R.; Machado, B.H. 2000: Activation of GABA receptors in the NTS of awake rats reduces the gain of baroreflex bradycardia. Autonomic Neuroscience: Basic and Clinical 84(1-2): 58-67
Neu, A.; Neuhoff, H.; Trube, G.; Fehr, S.; Ullrich, K.; Roeper, J.; Isbrandt, D. 2002: Activation of GABA(A) receptors by guanidinoacetate: a novel pathophysiological mechanism. Neurobiology of Disease 11(2): 298-307
Baufreton, J.; Garret, M.; Dovero, S.; Dufy, B.; Bioulac, B.; Taupignon, A. 2001: Activation of GABA(A) receptors in subthalamic neurons in vitro: properties of native receptors and inhibition mechanisms. Journal of Neurophysiology 86(1): 75-85
Otsuka, T.; Hashida, M.; Oka, T.; Kaba, H. 2001: Activation of GABA(A) receptors in the accessory olfactory bulb does not prevent the formation of an olfactory memory in mice. Journal of Veterinary Medical Science 63(7): 807-809
Jasnow, A.M.; Huhman, K.L. 2001: Activation of GABA(A) receptors in the amygdala blocks the acquisition and expression of conditioned defeat in Syrian hamsters. Brain Research 920(1-2): 142-150
Suzuki, Y.J.; Day, R.M.; Tan, C.C.; Sandven, T.H.; Liang, Q.; Molkentin, J.D.; Fanburg, B.L. 2003: Activation of GATA-4 by serotonin in pulmonary artery smooth muscle cells. Journal of Biological Chemistry 278(19): 17525-17531
Deng, J.; Harding, H.P.; Raught, B.; Gingras, A-Claude.; Berlanga, J.Jose.; Scheuner, D.; Kaufman, R.J.; Ron, D.; Sonenberg, N. 2002: Activation of GCN2 in UV-irradiated cells inhibits translation. Current Biology: Cb 12(15): 1279-1286
Hollander, M.C.; Sheikh, M.S.; Yu, K.; Zhan, Q.; Iglesias, M.; Woodworth, C.; Fornace, A.J. 2001: Activation of Gadd34 by diverse apoptotic signals and suppression of its growth inhibitory effects by apoptotic inhibitors. International Journal of Cancer 96(1): 22-31
Penzo-Mendèz, A.; Umbhauer, M.; Djiane, A.; Boucaut, J.-C.; Riou, J.-F.ço. 2003: Activation of Gbetagamma signaling downstream of Wnt-11/Xfz7 regulates Cdc42 activity during Xenopus gastrulation. Developmental Biology 257(2): 302-314
Maayani, S.; Schwarz, T.; Martinez, R.; Tagliente, T.M. 2001: Activation of Gi-coupled receptors releases a tonic state of inhibited platelet aggregation. Platelets 12(2): 94-98
Yoshida, A.; Ueda, H. 1999: Activation of Gi1 by lysophosphatidic acid receptor without ligand in the baculovirus expression system. Biochemical and Biophysical Research Communications 259(1): 78-84
Liu, J.C.; Baker, R.E.; Sun, C.; Sundmark, V.C.; Elsholtz, H.P. 2002: Activation of Go-coupled dopamine D2 receptors inhibits ERK1/ERK2 in pituitary cells. a key step in the transcriptional suppression of the prolactin gene. Journal of Biological Chemistry 277(39): 35819-35825
Beaver, C.J.; Ji, Q.H.; Jin, X.T.; Daw, N.W. 2002: Activation of Group IIi mGluRs increases the activity of neurons in area 17 of the cat. Visual Neuroscience 19(3): 355-364
Meng, J.; Casey, P.J. 2002: Activation of Gz attenuates Rap1-mediated differentiation of PC12 cells. Journal of Biological Chemistry 277(45): 43417-43424
Zhou, X.; Lynch, I.J.; Xia, S.L.; Wingo, C.S. 2000: Activation of H(+)-K(+)-ATPase by CO(2) requires a basolateral Ba(2+)-sensitive pathway during K restriction. American Journal of Physiology. Renal Physiology 279(1): F153-F160
Salem, I.A. 2001: Activation of H2O2 by Amberlyst-15 resin supported with copper(II)-complexes towards oxidation of crystal violet. Chemosphere 44(5): 1109-1119
Kamura, T.; Sato, S.; Iwai, K.; Czyzyk-Krzeska, M.; Conaway, R.C.; Conaway, J.W. 2000: Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex. Proceedings of the National Academy of Sciences of the United States of America 97(19): 10430-10435
Larsson, M.; Fonteneau, J-Francois.; Lirvall, M.; Haslett, P.; Lifson, J.D.; Bhardwaj, N. 2002: Activation of HIV-1 specific CD4 and CD8 T cells by human dendritic cells: roles for cross-presentation and non-infectious HIV-1 virus. Aids 16(10): 1319-1329
Yoshida, T.; Okuda, K.; Xin, K.Q.; Tadokoro, K.; Fukushima, J.; Toda, S.; Hagiwara, E.; Hamajima, K.; Koshino, T.; Saito, T. 2001: Activation of HIV-1-specific immune responses to an HIV-1 vaccine constructed from a replication-defective adenovirus vector using various combinations of immunization protocols. Clinical and Experimental Immunology 124(3): 445-452
MacLeod, R.A.F.; Nagel, S.; Kaufmann, M.; Janssen, J.W.G.; Drexler, H.G. 2003: Activation of HOX11L2 by juxtaposition with 3'-BCL11B in an acute lymphoblastic leukemia cell line (HPB-ALL) with t(5;14)(q35;q32.2). Genes Chromosomes and Cancer 37(1): 84-91
Torgeman, A.; Ben-Aroya, Z.; Grunspan, A.; Zelin, E.; Butovsky, E.; Hallak, M.; Löchelt, M.; Flügel, R.M.; Livneh, E.; Wolfson, M.; Kedar, I.; Aboud, M. 2001: Activation of HTLV-I long terminal repeat by stress-inducing agents and protection of HTLV-I-infected T-cells from apoptosis by the viral tax protein. Experimental Cell Research 271(1): 169-179
Püls, J.; Fischer, W.; Haas, R. 2002: Activation of Helicobacter pylori CagA by tyrosine phosphorylation is essential for dephosphorylation of host cell proteins in gastric epithelial cells. Molecular Microbiology 43(4): 961-969
Yahiro, K.; Niidome, T.; Kimura, M.; Hatakeyama, T.; Aoyagi, H.; Kurazono, H.; Imagawa, K.i.; Wada, A.; Moss, J.; Hirayama, T. 1999: Activation of Helicobacter pylori VacA toxin by alkaline or acid conditions increases its binding to a 250-kDa receptor protein-tyrosine phosphatase beta. Journal of Biological Chemistry 274(51): 36693-36699
Shirai, M.; Fujinaga, R.; Akada, J.K.; Nakazawa, T. 1999: Activation of Helicobacter pylori ureA promoter by a hybrid Escherichia coli-H. pylori rpoD gene in E. coli. Gene 239(2): 351-359
Dierks, T.; Linden, D.E.; Jandl, M.; Formisano, E.; Goebel, R.; Lanfermann, H.; Singer, W. 1999: Activation of Heschl's gyrus during auditory hallucinations. Neuron 22(3): 615-621
Sun, S.C.; Harhaj, E.W.; Xiao, G.; Good, L. 2000: Activation of I-kappaB kinase by the HTLV type 1 Tax protein: mechanistic insights into the adaptor function of IKKgamma. Aids Research and Human Retroviruses 16(16): 1591-1596
Blindt, Rüdiger.; Bosserhoff, A-K.; vom Dahl, Jürgen.; Hanrath, P.; Schrör, K.; Hohlfeld, T.; Meyer-Kirchrath, J. 2002: Activation of IP and EP(3) receptors alters cAMP-dependent cell migration. European Journal of Pharmacology 444(1-2): 31-37
Marino, M.; Distefano, E.; Pallottini, V.; Caporali, S.; Bruscalupi, G.; Trentalance, A. 2001: Activation of IP(3)-protein kinase C-alpha signal transduction pathway precedes the changes of plasma cholesterol, hepatic lipid metabolism and induction of low-density lipoprotein receptor expression in 17-beta-oestradiol-treated rats. Experimental Physiology 86(1): 39-45
Lingohr, M.K.; Dickson, L.M.; McCuaig, J.F.; Hugl, S.R.; Twardzik, D.R.; Rhodes, C.J. 2002: Activation of IRS-2-mediated signal transduction by IGF-1, but not TGF-alpha or EGF, augments pancreatic beta-cell proliferation. Diabetes 51(4): 966-976
Cobb, S.R.; Larkman, P.M.; Bulters, D.O.; Oliver, L.; Gill, C.H.; Davies, C.H. 2003: Activation of Ih is necessary for patterning of mGluR and mAChR induced network activity in the hippocampal CA3 region. Neuropharmacology 44(3): 293-303
Lallena, M.J.; Diaz-Meco, M.T.; Bren, G.; Payá, C.V.; Moscat, J. 1999: Activation of IkappaB kinase beta by protein kinase C isoforms. Molecular and Cellular Biology 19(3): 2180-2188
Negoro, S.; Kunisada, K.; Tone, E.; Funamoto, M.; Oh, H.; Kishimoto, T.; Yamauchi-Takihara, K. 2000: Activation of JAK/STAT pathway transduces cytoprotective signal in rat acute myocardial infarction. Cardiovascular Research 47(4): 797-805
Mazière, C.; Conte, M.A.; Mazière, J.C. 2001: Activation of JAK2 by the oxidative stress generated with oxidized low-density lipoprotein. Free Radical Biology and Medicine 31(11): 1334-1340
Rojas, M.; Olivier, M.; García, L.F. 2002: Activation of JAK2/STAT1-alpha-dependent signaling events during Mycobacterium tuberculosis-induced macrophage apoptosis. Cellular Immunology 217(1-2): 58-66
Zhang, C.; Kawauchi, J.; Adachi, M.T.; Hashimoto, Y.; Oshiro, S.; Aso, T.; Kitajima, S. 2001: Activation of JNK and transcriptional repressor ATF3/LRF1 through the IRE1/TRAF2 pathway is implicated in human vascular endothelial cell death by homocysteine. Biochemical and Biophysical Research Communications 289(3): 718-724
Hochbaum, D.; Tanos, T.; Ribeiro-Neto, F.; Altschuler, D.; Coso, O.A. 2003: Activation of JNK by Epac is independent of its activity as a Rap guanine nucleotide exchanger. Journal of Biological Chemistry 278(36): 33738-33746
Luo, J.; Sun, Y.; Lin, H.; Qian, Y.; Li, Z.; Leonard, S.S.; Huang, C.; Shi, X. 2003: Activation of JNK by vanadate induces a Fas-associated death domain (FADD)-dependent death of cerebellar granule progenitors in vitro. Journal of Biological Chemistry 278(7): 4542-4551
Chuang, S.M.; Liou, G.Y.; Yang, J.L. 2000: Activation of JNK, p38 and ERK mitogen-activated protein kinases by chromium(VI) is mediated through oxidative stress but does not affect cytotoxicity. Carcinogenesis 21(8): 1491-1500
Kolodziejczyk, S.M.; Walsh, G.S.; Balazsi, K.; Seale, P.; Sandoz, J.; Hierlihy, A.M.; Rudnicki, M.A.; Chamberlain, J.S.; Miller, F.D.; Megeney, L.A. 2001: Activation of JNK1 contributes to dystrophic muscle pathogenesis. Current Biology: Cb 11(16): 1278-1282
She, Q.-B.; Ma, W.-Y.; Zhong, S.; Dong, Z. 2002: Activation of JNK1, RSK2, and MSK1 is involved in serine 112 phosphorylation of Bad by ultraviolet B radiation. Journal of Biological Chemistry 277(27): 24039-24048
De Cesaris, P.; Starace, D.; Starace, G.; Filippini, A.; Stefanini, M.; Ziparo, E. 1999: Activation of Jun N-terminal kinase/stress-activated protein kinase pathway by tumor necrosis factor alpha leads to intercellular adhesion molecule-1 expression. Journal of Biological Chemistry 274(41): 28978-28982
Ammit, A.J.; Kane, S.A.; Panettieri, R.A. 1999: Activation of K-p21ras and N-p21ras, but not H-p21ras, is necessary for mitogen-induced human airway smooth-muscle proliferation. American Journal of Respiratory Cell and Molecular Biology 21(6): 719-727
Kabakov, A.Y. 1998: Activation of KATP channels by Na/K pump in isolated cardiac myocytes and giant membrane patches. Biophysical Journal 75(6): 2858-2867
Dupuis, D.S.; Schrøder, R.L.; Jespersen, T.; Christensen, J.K.; Christophersen, P.; Jensen, B.S.; Olesen, Søren.P. 2002: Activation of KCNQ5 channels stably expressed in HEK293 cells by BMS-204352. European Journal of Pharmacology 437(3): 129-137
Vieira, J.; O'Hearn, P.; Kimball, L.; Chandran, B.; Corey, L. 2001: Activation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) lytic replication by human cytomegalovirus. Journal of Virology 75(3): 1378-1386
Hamada, E.; Nishida, T.; Uchiyama, Y.; Nakamura, J.; Isahara, K.; Kazuo, H.; Huang, T.P.; Momoi, T.; Ito, T.; Matsuda, H. 1999: Activation of Kupffer cells and caspase-3 involved in rat hepatocyte apoptosis induced by endotoxin. Journal of Hepatology 30(5): 807-818
Luckey, S.W.; Petersen, D.R. 2001: Activation of Kupffer cells during the course of carbon tetrachloride-induced liver injury and fibrosis in rats. Experimental and Molecular Pathology 71(3): 226-240
Chen, G.G.; Lau, W.Y.; Lai, P.B.S.; Chun, Y.S.; Chak, E.C.W.; Leung, B.C.S.; Lam, I.K.Y.; Lee, J.F.Y.; Chui, A.K.K. 2002: Activation of Kupffer cells inhibits tumor growth in a murine model system. International Journal of Cancer 99(5): 713-720
Brunini, T.M.C.; Roberts, N.B.; Yaqoob, M.M.; Reis, P.F.; Ellory, J.C.; Mann, G.E.; Mendes-Ribeiro, A.C. 2002: Activation of L-arginine transport in peripheral blood mononuclear cells in chronic renal failure. Pflugers Archiv: European Journal of Physiology 445(1): 147-151
Robidoux, J.; Simoneau, L.; Masse, A.; Lafond, J. 2000: Activation of L-type calcium channels induces corticotropin-releasing factor secretion from human placental trophoblasts. Journal of Clinical Endocrinology and Metabolism 85(9): 3356-3364
Jørgensen, N.R.; Teilmann, S.C.; Henriksen, Z.; Civitelli, R.; Sørensen, O.H.; Steinberg, T.H.; Civitelli, R. 2003: Activation of L-type calcium channels is required for gap junction-mediated intercellular calcium signaling in osteoblastic cells. Journal of Biological Chemistry 278(6): 4082-4086
Sharma, P.; Singh, D.P.; Fatma, N.; Chylack, L.T.; Shinohara, T. 2000: Activation of LEDGF gene by thermal-and oxidative-stresses. Biochemical and Biophysical Research Communications 276(3): 1320-1324
Sumi, T.; Matsumoto, K.; Shibuya, A.; Nakamura, T. 2001: Activation of LIM kinases by myotonic dystrophy kinase-related Cdc42-binding kinase alpha. Journal of Biological Chemistry 276(25): 23092-23096
Calabresi, P.; Centonze, D.; Gubellini, P.; Bernardi, G. 1999: Activation of M1-like muscarinic receptors is required for the induction of corticostriatal LTP. Neuropharmacology 38(2): 323-326
Huang, T.S.; Shu, C.H.; Chao, Y.; Chen, S.N.; Chen, L.L. 2000: Activation of MAD 2 checkprotein and persistence of cyclin B1/CDC 2 activity associate with paclitaxel-induced apoptosis in human nasopharyngeal carcinoma cells. Apoptosis 5(3): 235-241
Slevin, M.; Krupinski, J.; Slowik, A.; Rubio, F.; Szczudlik, A.; Gaffney, J. 2000: Activation of MAP kinase (ERK-1/ERK-2), tyrosine kinase and VEGF in the human brain following acute ischaemic stroke. Neuroreport 11(12): 2759-2764
Molero, J.C.; Pérez, C.; Martínez, C.; Villar, M.; Andrés, A.; Fermín, Y.; Carrascosa, J.M. 2002: Activation of MAP kinase by insulin and vanadate in adipocytes from young and old rats. Molecular and Cellular Endocrinology 189(1-2): 77-84
Wu, Y.; Hiwasa, T.; Isogai, E.; Sonoda, T.; Kita, K.; Chen, Z.; Sugaya, S.; Yamamori, H.; Tanzawa, H.; Suzuki, N. 1998: Activation of MAP kinases by 5-fluorouracil in a 5-fluorouracil-resistant variant human cell line derived from a KT breast cancer cell line. International Journal of Oncology 13(6): 1241-1245
Douziech, N.; Calvo, E.; Lainé, J.; Morisset, J. 1999: Activation of MAP kinases in growth responsive pancreatic cancer cells. Cellular Signalling 11(8): 591-602
Choi, J-Sub.; Kim, J-A.; Joo, C-Ki. 2003: Activation of MAPK and CREB by GM1 induces survival of RGCs in the retina with axotomized nerve. IOVS Investigative Ophthalmology and Visual Science 44(4): 1747-1752
Smith, J.; Yu, R.; Hinkle, P.M. 2001: Activation of MAPK by TRH requires clathrin-dependent endocytosis and PKC but not receptor interaction with beta-arrestin or receptor endocytosis. Molecular Endocrinology 15(9): 1539-1548
Cerovac, Z.; Ban, J.; Morinville, A.; Yaccato, K.; Shaver, A.; Maysinger, D. 1999: Activation of MAPK by potassium bisperoxo(1,10-phenanthroline)oxovanadate (V). Neurochemistry International 34(4): 337-344
Naor, Z.; Benard, O.; Seger, R. 2000: Activation of MAPK cascades by G-protein-coupled receptors: The case of gonadotropin-releasing hormone receptor. Trends in Endocrinology and Metabolism: Tem 11(3): 91-99
Harris, D.; Bonfil, D.; Chuderland, D.; Kraus, S.; Seger, R.; Naor, Z. 2002: Activation of MAPK cascades by GnRH: ERK and Jun N-terminal kinase are involved in basal and GnRH-stimulated activity of the glycoprotein hormone LHbeta-subunit promoter. Endocrinology 143(3): 1018-1025
Eguchi, S.; Dempsey, P.J.; Frank, G.D.; Motley, E.D.; Inagami, T. 2001: Activation of MAPKs by angiotensin Ii in vascular smooth muscle cells. Metalloprotease-dependent EGF receptor activation is required for activation of ERK and p38 MAPK but not for JNK. Journal of Biological Chemistry 276(11): 7957-7962
Parenti, A.; Cui, X.L.; Hopfer, U.; Ziche, M.; Douglas, J.G. 2000: Activation of MAPKs in proximal tubule cells from spontaneously hypertensive and control Wistar-Kyoto rats. Hypertension 35(5): 1160-1166
Wu, H.; Rothermel, B.; Kanatous, S.; Rosenberg, P.; Naya, F.J.; Shelton, J.M.; Hutcheson, K.A.; DiMaio, J.M.; Olson, E.N.; Bassel-Duby, R.; Williams, R.S. 2001: Activation of MEF2 by muscle activity is mediated through a calcineurin-dependent pathway. EMBO Journal 20(22): 6414-6423
Kharbanda, S.; Pandey, P.; Yamauchi, T.; Kumar, S.; Kaneki, M.; Kumar, V.; Bharti, A.; Yuan, Z.M.; Ghanem, L.; Rana, A.; Weichselbaum, R.; Johnson, G.; Kufe, D. 2000: Activation of MEK kinase 1 by the c-Abl protein tyrosine kinase in response to DNA damage. Molecular and Cellular Biology 20(14): 4979-4989
Prusty, D.; Park, B.-H.; Davis, K.E.; Farmer, S.R. 2002: Activation of MEK/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor gamma (PPARgamma ) and C/EBPalpha gene expression during the differentiation of 3T3-L1 preadipocytes. Journal of Biological Chemistry 277(48): 46226-46232
Zhu, X.; Rottkamp, C.A.; Hartzler, A.; Sun, Z.; Takeda, A.; Boux, H.; Shimohama, S.; Perry, G.; Smith, M.A. 2001: Activation of MKK6, an upstream activator of p38, in Alzheimer's disease. Journal of Neurochemistry 79(2): 311-318
Liu, Y.F.; Dorow, D.; Marshall, J. 2000: Activation of MLK2-mediated signaling cascades by polyglutamine-expanded huntingtin. Journal of Biological Chemistry 275(25): 19035-19040
Koike, T.; Kuzuya, M.; Asai, T.; Kanda, S.; Cheng, X.W.; Watanabe, K.; Banno, Y.; Nozawa, Y.; Iguchi, A. 2000: Activation of MMP-2 by Clostridium difficile toxin B in bovine smooth muscle cells. Biochemical and Biophysical Research Communications 277(1): 43-46
Pattamapun, K.; Tiranathanagul, S.; Yongchaitrakul, T.; Kuwatanasuchat, J.; Pavasant, P. 2003: Activation of MMP-2 by Porphyromonas gingivalis in human periodontal ligament cells. Journal of Periodontal Research 38(2): 115-121
Watabe, M.; Kakeya, H.; Onose, R.; Osada, H. 2000: Activation of MST/Krs and c-Jun N-terminal kinases by different signaling pathways during cytotrienin A-induced apoptosis. Journal of Biological Chemistry 275(12): 8766-8771
Doutheil, J.; Althausen, S.; Gissel, C.; Paschen, W. 1999: Activation of MYD116 (gadd34) expression following transient forebrain ischemia of rat: Implications for a role of disturbances of endoplasmic reticulum calcium homeostasis. Brain Research. Molecular Brain Research 63(2): 225-232
Muto, A.; Tashiro, S.; Tsuchiya, H.; Kume, A.; Kanno, M.; Ito, E.; Yamamoto, M.; Igarashi, K. 2002: Activation of Maf/AP-1 repressor Bach2 by oxidative stress promotes apoptosis and its interaction with promyelocytic leukemia nuclear bodies. Journal of Biological Chemistry 277(23): 20724-20733
Valverde, M.A.; Hardy, S.P.; Díaz, M. 2002: Activation of Maxi Cl(-) channels by antiestrogens and phenothiazines in NIH3T3 fibroblasts. Steroids 67(6): 439-445
Yamamoto, S.; Yang, G.; Zablocki, D.; Liu, J.; Hong, C.; Kim, S-Jung.; Soler, S.; Odashima, M.; Thaisz, J.; Yehia, G.; Molina, C.A.; Yatani, A.; Vatner, D.E.; Vatner, S.F.; Sadoshima, J. 2003: Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy. Journal of Clinical Investigation 111(10): 1463-1474
Antczak, T.; Graczyk, J.; Szczesna Antczak, M.; Bielecki, S. 2002: Activation of Mucor circinelloides lipase in organic medium. Journal of Molecular Catalysis B Enzymatic (19-20): 287-294, 2 December
Liu, Q.; Tonai, T.; Ueda, N. 2002: Activation of N-acylethanolamine-releasing phospholipase D by polyamines. Chemistry and Physics of Lipids 115(1-2): 77-84
Bains, J.S.; Ferguson, A.V. 1999: Activation of N-methyl-D-aspartate receptors evokes calcium spikes in the dendrites of rat hypothalamic paraventricular nucleus neurons. Neuroscience 90(3): 885-891
Hermenegildo, C.; Monfort, P.; Felipo, V. 2000: Activation of N-methyl-D-aspartate receptors in rat brain in vivo following acute ammonia intoxication: characterization by in vivo brain microdialysis. Hepatology 31(3): 709-715
Li, W-Gen.; Stoll, L.L.; Rice, J.B.; Xu, S-Ping.; Miller, F.J.; Chatterjee, P.; Hu, L.; Oberley, L.W.; Spector, A.A.; Weintraub, N.L. 2003: Activation of NAD(P)H oxidase by lipid hydroperoxides: Mechanism of oxidant-mediated smooth muscle cytotoxicity. Free Radical Biology and Medicine 34(7): 937-946
Wautier, M.P.; Chappey, O.; Corda, S.; Stern, D.M.; Schmidt, A.M.; Wautier, J.L. 2001: Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. American Journal of Physiology. Endocrinology and Metabolism 280(5): E685-E694
Wu, G.S.; Rao, N.A. 1999: Activation of NADPH oxidase by docosahexaenoic acid hydroperoxide and its inhibition by a novel retinal pigment epithelial protein. IOVS Investigative Ophthalmology and Visual Science 40(5): 831-839
Li, J.-M.; Gall, N.P.; Grieve, D.J.; Chen, M.; Shah, A.M. 2002: Activation of NADPH oxidase during progression of cardiac hypertrophy to failure. Hypertension 40(4): 477-484
Shimohama, S.; Tanino, H.; Kawakami, N.; Okamura, N.; Kodama, H.; Yamaguchi, T.; Hayakawa, T.; Nunomura, A.; Chiba, S.; Perry, G.; Smith, M.A.; Fujimoto, S. 2000: Activation of NADPH oxidase in Alzheimer's disease brains. Biochemical and Biophysical Research Communications 273(1): 5-9
Cherny, V.V.; Henderson, L.M.; Xu, W.; Thomas, L.L.; Decoursey, T.E. 2001: Activation of NADPH oxidase-related proton and electron currents in human eosinophils by arachidonic acid. Journal of Physiology 535(Pt 3): 783-794
Xu-Hanshi; Ye-Rengao; Sun-Lin 2001: Activation of NF - kappaB signaling pathway in peripheral blood mononuclear cells of patients with systemic lupus erythematosus. Zhonghua Pifuke Zazhi 34(1): 18-21
Roberts, J.R.; Rowe, P.A.; Demaine, A.G. 2002: Activation of NF-kappaB and MAP kinase cascades by hypothermic stress in endothelial cells. Cryobiology 44(2): 161-169
Bonetti, B.; Stegagno, C.; Cannella, B.; Rizzuto, N.; Moretto, G.; Raine, C.S. 1999: Activation of NF-kappaB and c-jun transcription factors in multiple sclerosis lesions. Implications for oligodendrocyte pathology. American Journal of Pathology 155(5): 1433-1438
Wang, Q.; Kim, S.; Wang, X.; Evers, B.M. 2000: Activation of NF-kappaB binding in HT-29 colon cancer cells by inhibition of phosphatidylinositol 3-kinase. Biochemical and Biophysical Research Communications 273(3): 853-858
Jiménez, L.A.; Thompson, J.; Brown, D.A.; Rahman, I.; Antonicelli, F.; Duffin, R.; Drost, E.M.; Hay, R.T.; Donaldson, K.; MacNee, W. 2000: Activation of NF-kappaB by PM(10) occurs via an iron-mediated mechanism in the absence of IkappaB degradation. Toxicology and Applied Pharmacology 166(2): 101-110
Choe, W.; Volsky, D.J.; Potash, M.Jane. 2002: Activation of NF-kappaB by R5 and X4 human immunodeficiency virus type 1 induces macrophage inflammatory protein 1alpha and tumor necrosis factor alpha in macrophages. Journal of Virology 76(10): 5274-5277
Darnay, B.G.; Ni, J.; Moore, P.A.; Aggarwal, B.B. 1999: Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif. Journal of Biological Chemistry 274(12): 7724-7731
Sakai, T.; Kurokouchi, K.; Ishiguro, N.; Kambe, F.; Takigawa, M.; Iwata, H.; Seo, H. 1998: Activation of NF-kappaB by TNF-alpha in human chondrosarcoma HCS-2/8 cells. Environmental Medicine 42(2): 118-120
Molestina, R.E.; Payne, T.Matthew.; Coppens, I.; Sinai, A.P. 2003: Activation of NF-kappaB by Toxoplasma gondii correlates with increased expression of antiapoptotic genes and localization of phosphorylated IkappaB to the parasitophorous vacuole membrane. Journal of Cell Science 116(Pt 21): 4359-4371
Purcell, N.H.; Yu, C.; He, D.; Xiang, J.; Paran, N.; DiDonato, J.A.; Yamaoka, S.; Shaul, Y.; Lin, A. 2001: Activation of NF-kappaB by hepatitis B virus X protein through an IkappaB kinase-independent mechanism. American Journal of Physiology. Gastrointestinal and Liver Physiology 280(4): G669-G677
Gil, J.; Alcami, J.; Esteban, M. 2000: Activation of NF-kappaB by the dsRNA-dependent protein kinase, PKR involves the IkappaB kinase complex. Oncogene 19(11): 1369-1378
Pati, S.; Cavrois, M.; Guo, H.G.; Foulke, J.S.; Kim, J.; Feldman, R.A.; Reitz, M. 2001: Activation of NF-kappaB by the human herpesvirus 8 chemokine receptor ORF74: evidence for a paracrine model of Kaposi's sarcoma pathogenesis. Journal of Virology 75(18): 8660-8673
Han, S.Y.; Choung, S.Y.; Paik, I.S.; Kang, H.J.; Choi, Y.H.; Kim, S.J.; Lee, M.O. 2000: Activation of NF-kappaB determines the sensitivity of human colon cancer cells to TNFalpha-induced apoptosis. Biological and Pharmaceutical Bulletin 23(4): 420-426
Weber, A.J.; Soong, G.; Bryan, R.; Saba, S.; Prince, A. 2001: Activation of NF-kappaB in airway epithelial cells is dependent on CFTR trafficking and Cl- channel function. American Journal of Physiology. Lung Cellular and Molecular Physiology 281(1): L71-L78
Ali, N.N.; Gilston, V.; Winyard, P.G. 1999: Activation of NF-kappaB in human osteoblasts by stimulators of bone resorption. Febs Letters 460(2): 315-320
Woods, J.S.; Ellis, M.E.; Dieguez-Acuña, F.J.; Corral, J. 1999: Activation of NF-kappaB in normal rat kidney epithelial (NRK52E) cells is mediated via a redox-insensitive, calcium-dependent pathway. Toxicology and Applied Pharmacology 154(3): 219-227
Gómez-Garre, D.; Largo, R.; Tejera, N.; Fortes, J.; Manzarbeitia, F.; Egido, J. 2001: Activation of NF-kappaB in tubular epithelial cells of rats with intense proteinuria: role of angiotensin Ii and endothelin-1. Hypertension 37(4): 1171-1178
Mogensen, T.H.; Melchjorsen, J.; Höllsberg, P.; Paludan, Søren.R. 2003: Activation of NF-kappa B in virus-infected macrophages is dependent on mitochondrial oxidative stress and intracellular calcium: downstream involvement of the kinases TGF-beta-activated kinase 1, mitogen-activated kinase/extracellular signal-regulated kinase kinase 1, and I kappa B kinase. Journal of Immunology 170(12): 6224-6233
True, A.L.; Rahman, A.; Malik, A.B. 2000: Activation of NF-kappaB induced by H(2)O(2) and TNF-alpha and its effects on ICAM-1 expression in endothelial cells. American Journal of Physiology. Lung Cellular and Molecular Physiology 279(2): L302-L311
Müller, M.; Morotti, A.; Ponzetto, C. 2002: Activation of NF-kappaB is essential for hepatocyte growth factor-mediated proliferation and tubulogenesis. Molecular and Cellular Biology 22(4): 1060-1072
Shimamura, T.; Hsu, T-Chen.; Colburn, N.H.; Bejcek, B.E. 2002: Activation of NF-kappaB is required for PDGF-B chain to transform NIH3T3 cells. Experimental Cell Research 274(1): 157-167
Hay, D.C.; Beers, C.; Cameron, V.; Thomson, L.; Flitney, F.W.; Hay, R.T. 2003: Activation of NF-kappaB nuclear transcription factor by flow in human endothelial cells. Biochimica et Biophysica Acta 1642(1-2): 33-44
Geymayer, S.; Doppler, W. 2000: Activation of NF-kappaB p50/p65 is regulated in the developing mammary gland and inhibits STAT5-mediated beta-casein gene expression. FASEB Journal 14(9): 1159-1170
Liu, P.; Kimmoun, E.; Legrand, Aès.; Sauvanet, A.; Degott, C.; Lardeux, B.; Bernuau, D. 2002: Activation of NF-kappa B, AP-1 and STAT transcription factors is a frequent and early event in human hepatocellular carcinomas. Journal of Hepatology 37(1): 63-71
Hubbard, A.K.; Timblin, C.R.; Shukla, A.; Rincón, M.; Mossman, B.T. 2002: Activation of NF-kappaB-dependent gene expression by silica in lungs of luciferase reporter mice. American Journal of Physiology. Lung Cellular and Molecular Physiology 282(5): L968-L975
Jeon, Y.J.; Han, S.B.; Ahn, K.S.; Kim, H.M. 1999: Activation of NF-kappaB/Rel in angelan-stimulated macrophages. Immunopharmacology 43(1): 1-9
Kim, D.W.; Sovak, M.A.; Zanieski, G.; Nonet, G.; Romieu-Mourez, R.; Lau, A.W.; Hafer, L.J.; Yaswen, P.; Stampfer, M.; Rogers, A.E.; Russo, J.; Sonenshein, G.E. 2000: Activation of NF-kappaB/Rel occurs early during neoplastic transformation of mammary cells. Carcinogenesis 21(5): 871-879
Manninen, A.; Huotari, P.; Hiipakka, M.; Renkema, G.H.; Saksela, K. 2001: Activation of NFAT-dependent gene expression by Nef: conservation among divergent Nef alleles, dependence on SH3 binding and membrane association, and cooperation with protein kinase C-theta. Journal of Virology 75(6): 3034-3037